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Abstract 
 
The marine environment is a prolific and largely unexplored source for the prospection 
of bioactive compounds. The isolation of such substances from marine microorganisms 
has gained increasing interest over the last decade. Marine fungi are known to produce a 
great variety of secondary metabolites with unique chemical structures that have appealing 
bioactivities. 
Cancer is currently one of the most globally prevalent diseases. Furthermore, the 
incidence of cancer is steadily increasing, accompanying the ageing and growth of 
populations, as well as imbalanced life-styles and declining environmental conditions. The 
treatment of cancer is commonly (partially or solely) based on chemotherapy, however, 
resistance to common chemotherapeutic agents and hazardous side effects highlight the 
importance of the search for safer, more efficient and tumour-specific anticancer drugs.   
The first part of this study aimed to assess the in vitro anticancer activity of the crude 
ethyl extracts of three marine sponge-derived fungi, namely, Aspergillus similanensis 
KUFA 0013 (E1), Neosartorya paulistensis KUFC 7897 (E2) and Talaromyces 
trachsypermus KUFC 0021 (E3), and of one sea fan-derived fungi Neosartorya siamensis 
KUFA 0017 (E4) in a panel of seven cancer cell lines, glioblastoma (U251), malignant 
melanoma (A375), non-small cell lung cancer (A549), hepatocellular carcinoma (HepG2), 
colon carcinoma (HCT116 and HT29) and breast adenocarcinoma (MCF-7). Extracts E2 
and E4 significantly decreased cell proliferation in HepG2, A375 and HCT116 cancer 
cells, while extract E2 also decreased long-term cell proliferation in all three cell lines, and 
extract E4 in HepG2 and HCT116 cell lines, as observed by the clonogenic assay. Both 
extracts also managed to induce cell death in HCT116 and HepG2 cells. No genotoxic 
effect was observed, thus the observed cell death induction does not seem related to the 
induction of DNA damage, namely by the induction of DNA strand breaks.  
The second part of this study focused on nine compounds isolated from Neosartorya 
siamensis KUFA 0017 (E4), namely, 2,4-dihydroxy-3-methylacetophenon (C1), 
nortryptoquivaline (C2), chevalone C (C3), tryptoquivaline H (C4), fiscalin A (C5), epi-
fiscalin C (C6), epi-neofiscalin A (C7), epi-fiscalin A (C8) and tryptoquivaline F (C9), which 
were also screened for in vitro anticancer activity in the three cell lines in which extract E4 
presented most activity, namely in HepG2, A375 and HCT116 cells. Results showed that 
compounds C2, C3, C5, C6, C7 and C8 presented a significant anti-proliferative effect 
against the selected cell lines, with IC50 values ranging from 24 to 153 µM. The induction 
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of cell death was observed in HepG2 cells by compounds C2, C5, C7 and C8, and in 
HCT116 cells by compounds C2, C3 and C5. The induction of cell death is once more 
possibly unrelated to induction of DNA damage — at least to a point of induction of DNA 
strand breaks — as none of the compounds exhibited genotoxic activity assessed by the 
comet assay. 
In summary, crude ethyl extracts of the marine-derived fungi Neosartorya paulistensis 
and Neosartorya siamensis were shown to have anticancer activity against hepatocellular 
carcinoma, colon carcinoma and malignant melanoma cell lines. The activity of compounds 
isolated from N. siamensis was in most cases greater than that of the extract, presenting 
appreciable IC50 values, ranging from 24 to 153 µM, and considerable induction of cell 
death, with compounds exhibiting a range of 5 to 12% increase of cells presenting nuclear 
condensation. Further studies should be undertaken to elucidate the underlying 
mechanisms of action and molecular targets. 
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Resumo 
 
O meio marinho é um ambiente altamente prolífico e ainda parcamente explorado na 
procura de compostos bioactivos. O isolamento de compostos bioactivos provenientes de 
microorganismos marinhos tem adquirido particular relevância na última década. Os 
fungos marinhos são já reconhecidos pela produção de uma grande variedade de 
metabolitos secundários com estruturas químicas singulares, apresentando bioactividade 
de interesse.  
O cancro é actualmente uma das doenças com maior prevalência a nível global. A 
incidência do cancro tem aumentado consistentemente, acompanhando o 
envelhecimento e crescimento das populações, bem como estilos de vida pouco 
equilibrados e condições ambientais prejudiciais. O tratamento do cancro é habitualmente 
baseado, em parte ou exclusivamente, na quimioterapia, contudo, o aumento da 
resistência associada a agentes quimioterapêuticos de uso comum, acompanhado de 
efeitos secundários nefastos, revela a importância na pesquisa de drogas 
anticarcinogénicas mais seguras, eficientes e específicas.  
A primeira parte deste estudo baseou-se na avaliação da actividade anticarcinogénica 
in vitro de extractos de acetato de etilo de três fungos marinhos associados a esponjas, 
nomeadamente, Aspergillus similanensis KUFA 0013 (E1), Neosartorya paulistensis 
KUFC 7897 (E2) e Talaromyces trachsypermus KUFC 0021 (E3), e de um fungo 
associado a gorgónias, Neosartorya siamensis KUFA 0017 (E4), num painel de sete 
linhas celulares de cancro, nomeadamente, glioblastoma (U251), melanoma maligno 
(A375), carcinoma de pulmão de não-pequenas células (A549), carcinoma hepatocelular 
(HepG2), carcinoma do cólon (HCT116 e HT29) e adenocarcinoma da mama (MCF-7). 
Os extractos E2 e E4 levaram a uma diminuição significativa da proliferação celular em 
células HepG2, A375 e HCT116, enquanto que o extracto E2 diminuiu também a 
proliferação celular a longo termo nas mesmas três linhas celulares, sendo que o extracto 
E4 teve efeito similar em HepG2 e HCT116, tal como observado pelo ensaio clonogénico. 
Ambos os extractos induziram morte celular em células HCT116 e HepG2. Não foi 
observado qualquer efeito genotóxico, consequentemente é possível sugerir que a 
indução de morte celular observada não aparenta estar relacionada com a indução de 
danos no ADN, nomeadamente indução de quebras nas cadeias de ADN. 
A segunda parte deste estudo focou-se em nove compostos isolados de Neosartorya 
siamensis KUFA 0017, nomeadamente, 2,4-dihydroxy-3-methylacetophenon (C1), 
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nortryptoquivaline (C2), chevalone C (C3), tryptoquivaline H (C4), fiscalin A (C5), epi-
fiscalin C (C6), epi-neofiscalin A (C7), epi-fiscalin A (C8) e tryptoquivaline F (C9), que 
foram também analisados em termos de actividade anticarcinogénica in vitro nas três 
linhas celulares onde o extracto E4 apresentou maior actividade, especificamente em 
células HepG2, A375 e HCT116. Os resultados demonstraram que os compostos C2, C3, 
C5, C6, C7 e C8 apresentaram um efeito anti-proliferativo significativo contra as linhas 
celulares seleccionadas, com valores de IC50 a variar entre 24 a 153 µM. A indução de 
morte celular foi observada em HepG2 por via dos compostos C2, C5, C7 e C8, enquanto 
que em HCT116, por via dos compostos C2, C3 e C5. Mais uma vez, a indução de morte 
celular parece não estar relacionada com a indução de danos no ADN nomeadamente 
indução de quebras nas cadeias do ADN, uma vez que nenhum dos compostos exibiu 
actividade genotóxica observável pelo ensaio cometa. 
Em suma, os extractos de acetato de etilo dos fungos marinhos Neosartorya 
paulistensis e Neosartorya siamensis demonstraram possuir uma actividade 
anticarcinogénica relevante contra linhas celulares de carcinoma hepatocelular, 
carcinoma do cólon e melanoma maligno. A actividade dos compostos isolados de N. 
siamensis suplantou na sua maioria a actividade do extracto, apresentando valores de 
IC50 apreciáveis, numa gama de valores de IC50 entre 24 a 153 µM, e uma indução de 
morte celular considerável, onde os compostos induziram um aumento de 5 a 12% de 
células com núcleos condensados. Estudos futuros deverão procurar elucidar quais os 
mecanismos e alvos moleculares associados. 
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Preface 
 
In the last few decades, there has been an increasing demand for novel compounds 
with pharmaceutical applications. The marine environment has become a leading hotspot 
for the bio-prospection of bioactive compounds, and due to the notable diversity and 
unique chemical structures, marine sourced natural products possess interesting 
properties that deserve further research and development into biotechnological 
applications.   
This work was developed in the context of the project MARBIOTECH in the 
Interdisciplinary Centre of Marine and Environmental Research (CIIMAR) of the University 
of Porto, which aims to obtain bioactive compounds from marine organisms, with the 
objective of screening these compounds for a diversity of biological activities, such as 
allelopathic, antimicrobial, antifouling and anticancer activity. 
In this context, the aim of this study was to screen several extracts obtained from 
marine invertebrate-associated fungi for in vitro anticancer activity in a panel of cancer cell 
lines. The screening of anticancer activity was based on the observation of anti-
proliferative activity, cell death induction and genotoxic activity by induction of DNA 
damage (single strand breaks and alkali-labile sites). The following goal was to select 
extracts with demonstrated bioactivity and proceed to the subsequent isolation of 
compounds, and to screen these compounds for in vitro anticancer activity. 
In summary, this work is organized in four chapters. Chapter I is a brief review to the 
themes of cancer and bioactive compounds of marine origin. Chapter II and III are 
comprised by original manuscripts, of which the first has been submitted and the latter is 
to be submitted to a peer-reviewed international journal. Chapter IV presents an overall 
conclusion of the work and future perspectives, while the Appendix displays the protocols 
used during this work to a more extensive detail.  
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CHAPTER I  
GENERAL INTRODUCTION
  2 
CHAPTER I 
 3 
 
1.1. CANCER 
 
Cancer is the general denomination for a series of diseases associated to regulatory 
abnormalities in cell growth and homeostasis. Overall, more than 100 distinct types of 
cancer have been described (Hanahan & Weinberg, 2000).  
The etymology of the term “cancer” originates from the greek word karkinos, and its 
coinage is attributed to Hippocrates (460-370 B.C.), who made an analogy of the disease 
and its lesions to a moving, clasping crab. This early observation and appellation comes 
as no surprise, considering that in spite of cancer usually being considered a disease of 
the ‘modern ages’, it has accompanied both animals and mankind since time immemorial. 
The oldest description of cancerous lesions, in this case of breast cancer, dates back to 
Egypt in 3000 B.C. (Hajdu, 2011).  
Cancer currently represents a high economic and societal burden for both developed 
and developing countries. Several factors have been pinpointed as causative factors of 
cancer. Environmental factors account for around 90-95% of all cancers, while inherited 
genetic factors are involved in 5-10% of the cases (Anand et al., 2008). Examples of 
environmental factors that have been correlated with the onset of cancer are, for example, 
smoking tobacco, alcohol consumption, diet, obesity, infectious agents, environmental 
pollution, radiation and physical inactivity (Jemal et al., 2011). Ultimately, this disease is 
best fought by prevention, where prophylactic measures such as annual cancer 
screenings in critical age-groups, vaccination for viral-induced cancers, the consumption 
of fruit, vegetables, wholegrain foods, teas and spices, vitamins, physical exercise and 
caloric restrictions are deemed essential for the maintenance of good health and lowering 
of cancer risk factors (Anand et al., 2008). 
 
1.1.1. Demographics of cancer 
 
In the 2012 GLOBOCAN project, it was estimated that there was a worldwide incidence 
of 14.1 million new cancer cases, 32.6 million people living with cancer and 8.2 million 
deaths due to cancer. Over half of all cancer cases and cancer-related deaths occurred in 
developing countries. The five most common cancers are lung, breast, colorectal, prostate 
and stomach cancer. All the aforementioned cancers in the exception of prostate, and 
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including liver cancer, are considered to be the deadliest cancers, with the highest annual 
mortality rates. Considering the ageing and growth of the global populations, projections 
based on this study suggest an increase of 19.3 million new cases of cancer per annum 
by the year 2025 (Ferlay et al., 2013).  
 
1.1.1.1. Colorectal carcinoma 
 
Colorectal cancer is one of the most commonly diagnosed cancers on a global scale, 
arising each year 1.23 million new cases (Ferlay et al., 2010). Around 55% of the total 
colorectal cancer cases arise in more developed regions (Ferlay et al., 2013). 
Notwithstanding its decreasing tendency in developed countries due to increased 
awareness and anticipated detection, shifts in key risk factors such as smoking, alcohol 
abuse, obesity, high caloric intake, low vegetable and fruit intake and physical inactivity 
have lead to an increase in the number of cases (Ferlay et al., 2010; LeMarchand et al., 
1997). An important factor, however, is the hereditary factor involved in the development 
of colorectal cancer (Jasperson et al., 2010). 
 
1.1.1.2. Hepatocellular carcinoma 
 
The most current annual estimate for the incidence of primary liver cancers (PLC) is a 
total of approximately 780.000 cases diagnosed worldwide (Ferlay et al., 2013). The 
annual worldwide mortality rate is just as high, and in 2004 it was estimated that PLC was 
the cause of 1% of all deaths (Blachier et al., 2013; Nordenstedt et al., 2010). 
Consequently, in 2011 primary liver cancer held fifth and second place in the list of 
worldwide most common cancers and cause of cancer death, respectively (Jemal et al., 
2011). Hepatocellular cancer (HCC) represents around 85-90% of all PLC cases. This 
type of cancer is most prevalent amongst men, and its distribution is most centered in 
South-East and East Asia and West and Middle Africa populations (Jemal et al., 2011). 
This may be in part explained by the risk factors associated to hepatocellular carcinoma, 
which are mainly attributed to chronic infection by hepatitis B virus (HBV) and hepatitis C 
virus (HCV), accounting for 80 to 90% of all cases. Other risk factors that have been 
suggested as influential in the development of HCC carcinogenesis are alcohol, non-
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alcoholic fatty liver disease, diabetes, tobacco, oral contraceptives, obesity and exposure 
to dietary aflatoxin (El-Serag & Rudolph, 2007; Nordenstedt et al., 2010).  
 
1.1.1.3. Malignant melanoma 
 
Malignant melanoma is a type of skin cancer that origins from pigment-producing 
epidermal melanocytes. Common risk factors include exposure to ultraviolet light in 
sunbeds and sunlamps, history of sunburn, chronic sun exposure and familial genetic 
factors (Choi & Fisher, 2014; Ferlay et al., 2010; Shi et al., 2014). Melanoma of the skin 
was estimated to have caused 232.130 new cases and 55.488 deaths worldwide in 2012 
(Ferlay et al., 2013). Fortunately, primary melanomas have a high cure rate, with 98.3% of 
patients presenting a 5-year rate survival, however, when the metastatic process is 
initiated, the cancer becomes highly aggressive and seriously undermines the 5-year 
survival rate to about 16% (Garraway & Chin, 2011).  
 
1.1.2. The biology of cancer 
 
1.1.2.1. Carcinogenesis 
 
The process of carcinogenesis is defined as that by which normal cells gradually 
acquire a malignant, invasive profile. Cell division is an essential process that ensures the 
renovation and repopulation of tissues and organs. The cells involved in this proliferative 
activity are stem cells, which are able to divide and differentiate. Although every individual 
goes through the process of cell renewal daily, the total amount of cells in the body is 
maintained (Bertram, 2000). This occurs due to intricate control mechanisms that 
determine the extent of cell proliferation, but also govern cell death. The programmed 
death of cells is vital for the renewal of important tissues and removal of defective or 
damaged cells. However, the process of cell proliferation is dependent on several factors, 
such as the microenvironment cells are surrounded by, influence of exogenous factors 
and the accurate functioning of DNA control and repair mechanisms. The DNA molecule 
is inherently instable, so damage to the DNA can occur spontaneously due to replicative 
errors, errors in repair, or even by chemical induction (Cohen & Arnold, 2008). DNA 
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damage may also occur when induced by environmental carcinogens, which can be of 
chemical or physical nature (Bertram, 2000). Normal cells constantly ensure the 
maintenance of their DNA, by sensing and responding to DNA damage when it occurs 
and adequately repairing it. However, when a cell suffers a critical alteration in its DNA, 
which it is unable to repair, the cell usually enters a process of programmed cell death by 
apoptosis. Notwithstanding, when this does not occur and the damage to the DNA is 
maintained, the potential beginning of carcinogenesis is observed (Kryston et al., 2011). If 
this damage remains unrepaired and several other specific mutations appear, which may 
vary from a few dozen to thousands, remaining unchecked and allowed to accumulate, 
then the cell acquires a malignant profile (Greaves & Maley, 2012). These changes may 
take several years to take place. Mutations that promote oncogene expression and inhibit 
tumor suppressor gene expression are of critical importance (Babashah & Soleimani, 
2011). In addition, alterations in epigenetic mechanisms can lead to altered gene function 
and the onset of malignancy (Sharma et al., 2010).  
The most critical point that defines whether these genetic alterations are successful is 
the ability to proliferate and generate multiple clones bearing the same mutations. These 
accumulated mutations may confer cancer cell clones a selective advantage over other 
clones. The reproductive success of a malignant cell generates clone cells that no longer 
obey the strict homeostatic protocol of normal cells, ignoring the cooperative agenda of 
their regular counterparts, focusing instead on unrestrained multiplication and 
demonstrating phenotypic alterations that have been defined as the hallmarks of cancer 
(Greaves & Maley, 2012). Hanahan and Weinberg (2000) proposed the groundbreaking 
six hallmarks of cancer, which have more recently been updated to ten (Hanahan & 
Weinberg, 2000). These hallmarks represent distinctive features that are common to all 
types of cancer and are those responsible for tumour growth and dissemination of 
metastasis. The ten hallmarks are: sustained proliferative signaling, inducing 
angiogenesis, enabling replicative immortality, resisting cell death, evading growth 
suppressors, activating invasion and metastasis, tumour-promoting inflammation, avoiding 
immune destruction, deregulating cellular energetics and genome instability and mutation 
(Hanahan & Weinberg, 2011). 
The proliferation of cancer cells leads to a neoplasm, also known as a tumour. Not all 
tumours are malignant, benign tumours (e.g., melanocytic nevi) are not invasive or 
metastatic and do not cause significant health threats, thus they are not cancerous in 
nature.  Malignant tumours display high heterogeneity in terms of phenotypic expression, 
which result of the influence of both genetic and non-genetic factors. This heterogeneity 
may complicate therapeutic approach (Marusyk et al., 2012). 
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The development of metastasis is in fact the main cause of death in cancer patients. 
Metastasis are formed when a cancer cell originated from a primary tumour develops an 
invasive phenotype and invades surrounding tissue, eventually penetrating the 
microvasculature of either blood or lymphatic systems, i.e. intravasation. These 
transitioning cancer cells (CTC) circulate through the bloodstream until reaching small 
vessels in a distant tissue, where they then exit, i.e. extravasion. These cells must then 
evade the innate immune response in order to survive, and when successful, they must 
adapt to the new microenvironment and thus proliferate, forming a secondary tumour, i.e. 
colonization (Chaffer & Weinberg, 2011). Metastatic sources for common cancers are 
exemplified in Figure 1. 
 
 
 
 
 
 
 
 
 
 
 
It is widely accepted that tumours possess cancer cells that are heterogenous in terms 
of phenotype and function. Recent studies have shown that cancer cells in tumours obey 
to a hierarchy in terms of cells with tumorigenic and invasive potential. This hierarchy is 
consisted by stem cells, progenitor cells and differentiated cells. Cancer stem cells (CSC) 
lie on the top of this hierarchy, and they have been labeled as self-renewing and as the 
source of the heterogenous lineages of cancer cells contained in the tumour, as they are 
able to differentiate, much like normal stem cells (Sugihara & Saya, 2013). CSCs possess 
a high clonogenic potential, and are thought to be responsible for the enhancement 
tumour growth, local tissue invasion and the formation of distant metastasis (Sampieri & 
Figure 1 – Sources of metastasis for common cancers. Source: Mikael 
Häggström, via Wikimedia Commons, Creative Commons CC0 1.0. 
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Fodde, 2012). Recent research has tried to solidify the hypothesis of CSCs being the 
main culprits in the phenomenon of migration and metastasis. In fact, the latest studies 
suggest that CSCs may very well be the root of cancer, and highly responsible not only for 
the invasion by metastasis, but also for relapses in patients who have been in remission 
for several years, for CSCs can survive in dormancy for extended periods of time (Tirino 
et al., 2013). Considering that CSCs have also been found to be highly resistant to both 
chemotherapy and radiotherapy, efforts are being made to produce targeted therapy 
towards CSCs in hopes of limiting the aggressiveness of the cancer and its invasive 
potential, as well as eliminating residual cancer stem cells and mitigating relapses of the 
disease (Shiozawa et al., 2013). 
 
1.1.2.2. Programmed cell death and cancer 
 
Programmed cell death (PCD) is an essential mechanism involved in cell death and 
survival. There are three known types of PCD, namely apoptosis, autophagy and 
programmed necrosis. All these types of PCD are involved to some extent in the 
pathological process of cell death, and more specifically in this approach, in the 
development of cancer (Ouyang et al., 2012). 
Apoptosis is mediated by a strict intracellular program, which ultimately leads a cell 
exposed to a certain stimulus to pursue a path that leads to its own death (Kerr et al., 
1972). It is involved in several physiological processes, such as lymphocyte development 
and homeostasis, sculpting of tissue during embryonic development, destruction of cells 
with consequent proliferative replacement and physiologic involution (Taylor et al., 2008; 
Zhang et al., 2005). Disorders in apoptosis play a major role in pathogenesis, namely in 
cancer, neurological and cardiovascular disorders and autoimmune diseases (Favaloro et 
al., 2012).  
Autophagy is a highly regulated process, which plays a role in the elimination of 
dysfunctional or unnecessary cellular components. Autophagy is not only involved in 
normal cell homeostasis, development, fight against infection and disease, but also in the 
response to metabolic stress (Mizushima et al., 2008). Its course of action is followed 
when the unnecessary cellular components are trapped by autophagic vacuoles and their 
degradation is enforced by lysosomes. In fact, autophagy may play a pro-survival role or a 
pro-death role. This pro-death role has been suggested as being triggered in situations 
where apoptosis is inhibited or impeded, acting as a last resort. Autophagic cell death is 
proposed to occur when the autophagic process eliminates such a large portion of cellular 
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components that the cells’ function and viability are mortally compromised (Levine & 
Yuan, 2005). Nonetheless, autophagic induced cell death is still a controversial subject, as 
there is still no consensual evidence that autophagy can effectively kill a cell (Shen et al., 
2012). Moreover, autophagy may also trigger apoptosis and vice-versa. The exact 
mechanisms involved in the cross-talk between apoptosis and autophagy remain largely 
unclear, however, both seem to be regulated by Bcl-2 family proteins, and autophagic 
proteins (Atg) have been proposed as pro-apoptotic effectors and regulators of caspase 
induction (Ryter et al., 2014).  Autophagy plays a dual role in cancer, as it can be both 
tumour-suppressing by removing damaged organelles, toxic unfolded proteins and 
oncogenic proteins, or be tumour-promoting, by providing the cancer cells with substrates 
for metabolism, maintaining mitochondria and thus inducing stress-tolerance (White, 
2012).  
Necrosis is most commonly referred as uncontrolled cell death. In contrast, new forms 
of necrotic cell death have been described, such as necroptosis, are considered to have 
regulated signaling pathways, which in turn may be linked to cross-talk with apoptosis and 
autophagy (Feoktistova & Leverkus, 2014). Necrosis occurs when a cell is exposed to 
trauma, infection and toxins that cause damage beyond a threshold of feasible repair, and 
ultimately leads to cell and organelle swelling, loss of membrane integrity and the leakage 
of intracellular components to the extracellular medium, which in turn causes an 
aggravated inflammatory response by the immune system. This type of immune response 
is not only costly to the organism, but can also lead to the development of further damage 
to surrounding cells and tissues. This localized induction of inflammation may promote 
tumour growth (Vakkila & Lotze, 2004). Nonetheless, the exploitation of necrotic cell death 
in cancer therapy may be of interest (Ouyang et al., 2012).  
 
1.1.2.2.1. Apoptosis in cancer 
 
Apoptosis is characterized by a series of morphological and biochemical hallmarks, 
such as membrane blebbing, cell shrinkage, nuclear condensation and fragmentation, 
phosphatidylserine externalization, detachment from the cellular matrix, mitochondrial 
fragmentation amongst others (Elmore, 2007). In contrast with necrosis, where the leaking 
of cell content stimulates inflammation, apoptotic cells trigger direct chemotactic signaling 
to phagocytes, thus avoiding inflammation and damage to neighboring cells (Taylor et al., 
2008).  
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Apoptosis is triggered when an exogenous or endogenous stressor stimulates the cell 
to produce apoptotic signals, which cause regulatory proteins to initiate the apoptotic 
pathway. This process usually occurs either by the extrinsic or death receptor pathway or 
the intrinsic or mitochondrial pathway, which ultimately activate executioner caspases and 
induce cell death. Briefly, the extrinsic pathway initiates apoptosis by involving 
transmembrane receptor-mediated pathways, where cytokine ligands (e.g., TNF) bind to 
the death receptors (Fas), which will aggregate to the cell surface and form a Death 
Inducing Signaling Complex (DISC) that will then activate the caspase cascade (Elmore, 
2007). The intrinsic pathway occurs with the involvement of mitochondria, the Bcl-2 family 
proteins, which regulate mitochondrial permeability, and the p53 tumour suppressor 
protein, which regulates the Bcl-2 proteins. The initial response is based on a response to 
a stress stimulus, which is then sensed by cytosolic or intra-membrane molecules, that 
consequently send the signal to the mitochondria. This results in changes in the 
mitochondrial membrane, such as loss of mitochondrial membrane potential that 
increases protein permeability, the SMAC proteins (small mitochondria-derived activator 
of caspases) then exit the mitochondria and diffuse in the cytosol. SMAC proteins will bind 
to and deactivate inhibitor of apoptosis proteins (IAP), thus avoiding the arrest of the 
apoptotic pathway. The mitochondrial cytochrome c will bind to the apoptosis protease 
activating factor-1 (Apaf-1), thus a series of subsequent processes will create the 
apoptosome and activate the caspase cascade (Elmore, 2007; Khosravi-Far & Esposti, 
2004). 
Cancer cells manage to avoid the induction of apoptosis due to three main factors: 
reduced caspase function, imbalance of anti-apoptotic and pro-apoptotic proteins and 
impaired death receptor signaling. The reduction of apoptotic caspase activity, which 
comprises initiator caspases (e.g., caspase-2) and effector caspases (e.g., caspase-3), 
may lead to impaired apoptosis and carcinogenesis. Abnormalities in pathways involved in 
the signaling of death, such as the downregulation or impairment of receptors, lead to 
deficient signaling, thus the stimulus of apoptosis is reduced and may lead to 
carcinogenesis (Wong, 2011). Several proteins are involved in promoting or inhibiting 
apoptotic activity. The main proteins of interest involved in this process are proteins of the 
Bcl-2 family, p53 and IAPs.  
The Bcl-2 family is comprised of pro-apoptotic proteins (e.g. Bax, Bak, Bad, Bcl-XS, 
Bid, Bik ad Bim) and anti-apoptotic proteins (e.g., Bcl-2, Bcl-xL and Mcl-1), which are 
located in the outer mitochondrial membrane (Ouyang et al., 2012). An imbalance of 
expression of these proteins can cause a dysregulation of apoptosis, in particular when 
overexpressing anti-apoptotic proteins and underexpressing pro-apoptotic proteins. 
CHAPTER I 
 11 
Mutations in genes encoding these proteins are common to many cancers and may even 
lead to multi-drug resistance (Kelly & Strasser, 2011; Wong, 2011). 
 The protein p53 is the most notorious tumor suppressor protein, encoded by the gene 
TP53. It is regarded as the guardian of the genome, being responsible for apoptosis 
induction, autophagy modulation, cell cycle regulation, DNA repair, differentiation and 
development, DNA recombination, cell senescence, chromosomal segregation and gene 
amplification (Maiuri et al., 2010; Wong, 2011). Studies have shown that p53 is mutated in 
at least 50% of cancers (Bai & Zhu, 2006). The p53 tumour suppressor gene reacts when 
the cell suffers DNA damage, by arresting the cell cycle until the DNA is repaired. If p53 is 
mutated, cells will continue to divide disregarding the DNA damage, which may lead to the 
appearance of malignancy (Bai & Zhu, 2006). 
The inhibitor of apoptosis proteins (IAP) are involved in apoptosis, signal transduction, 
cytokinesis immunity, and are also endogenous caspase inhibitors. Overexpression of 
these proteins may lead to inhibition of apoptosis and promotion of pro-survival signals 
that contribute towards tumour proliferation (De Almagro & Vucic, 2012).  
 
1.1.3. Therapeutic approaches to cancer 
 
Early cancer treatments were mostly based on exploratory surgery resulting in the 
resection of cancerous lesions, even so, many lesions were deemed unresectable and 
afflicted patients were treated only with palliative medication. At the present time, the 
surgical approach to cancer treatment has been much improved due to the diagnostic 
imaging techniques which are now available, such as computed tomography (CT), 
ultrasound sonography, positron emission tomography (PET) and magnetic resonance 
imaging (MRI). The development of less invasive surgical techniques with the aid of 
scopes, video cameras, lasers and other technological tools has greatly aided patient 
survival and quality of life (Fisher, 2008). However, the effectiveness of surgical treatment 
is undermined when the cancer has spread to other organs by metastasis.  
The use of ionizing radiation for cancer treatment began in the 19th century, soon after 
the discovery of X-rays and radium, however, to a limited success, until the pioneering of 
fractioned radiotherapy in the early 20th century. Radiation therapy continued to evolve, in 
the light of technological advances in X-ray therapy, the development of intensity-
modulated radiation therapy and extensive studies on the response of tumours and cells 
to radiation. It was later found that ionizing radiation acts through several pathways, such 
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as the activation of cell surface receptors, induction of double strand DNA breaks, 
production of ceramide (a pro-apoptotic molecule) by cell-membrane sphyngomyelin, 
activation of intracellular signaling pathways and by bystander effect to other neighboring 
cells (Connell & Hellman, 2009). Currently, radiation therapy remains a standard 
treatment for several cancers, and is also frequently used in combination with surgery or 
chemotherapy to potentiate results (Siegel et al., 2012). 
In parallel, in beginning of the 20th century, efforts were made to develop 
chemotherapeutic agents with specificity towards cancer, by screening chemicals using 
transplantable tumour systems in rodents as models. The interest in screening for 
chemotherapeutical agents continued to rise, and major breakthroughs were achieved 
both during and in the aftermath of World War II, which lead to the use of many of the 
discovered chemotherapeutic agents in hematologic cancers. The discovery of truly 
successful chemotherapeutic agents only came to be in the 1960s, where the first cases 
of chemotherapy-induced remissions were observed. From hereon, the acceptance of this 
approach gave rise to the progress of more agents, as well as the development of 
adjuvant and combination chemotherapy (DeVita & Chu, 2008). Several types of 
chemotherapeutic drugs have been developed, such as alkylating agents, which damage 
the DNA (e.g., mechlorethamine and dacarbazine); antimetabolite agents, which induce 
cell death at S phase and inhibit enzymes responsible for RNA and DNA production (e.g., 
5-fluorouracil and cytarabine); compounds that interfere with enzymes involved in DNA 
replication, for example, by inhibiting topoisomerase enzymes responsible for DNA strand 
separation (e.g., doxorubicin, etoposide and topotecan); mitotic inhibitors, which inhibit the 
progression of mitosis and associated enzymes (e.g., taxol and vinblastine) and 
corticosteroids with cytotoxic and cytostatic activity (e.g., prednisone and dexamethasone) 
(Skeel & Khleif, 2011). Nonetheless, the use of chemotherapy faces several setbacks, as 
for example, the non-specific cytotoxic effect with high toxicity and giving rise to resistance 
(Gordon & Nelson, 2012; Hedigan, 2010). 
Common side effects related to current cancer therapies include cardiomyopathy, 
nausea, cognitive deficits, peripheral neuropathy, fatigue, infertility, osteopenia, 
osteoporosis and pulmonary dysfunction (Farrell et al., 2013; Saad et al., 2014; Siegel et 
al., 2012; Yahalom & Portlock, 2011). 
More recently, efforts have been made in developing targeted therapy, which is a more 
selective and mechanism-based treatment. Targeted cancer therapy is based on 
molecules that specifically block vital biochemical pathways or abnormal proteins that are 
essential for the survival and proliferation of tumours (Vanneman & Dranoff, 2012). Such 
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examples are hormone therapies, apoptosis inducers, immunotherapies, gene expression 
modulators, angiogenesis inhibitors, signal transduction inhibitors, and delivery molecules 
(e.g. nanoparticles) (Brannon-Peppas & Blanchette, 2012; Garzon et al., 2010; Jordan, 
2014; Vanneman & Dranoff, 2012; Wiezorek et al., 2010).  
 
 
1.2. MARINE SYSTEMS AS A SOURCE OF NATURAL BIOACTIVE COMPOUNDS 
 
 
The marine environment is home to an immensely vast and complex array of species 
and ecosystems, most of which remain undiscovered. This does not come as a surprise, 
considering that the ocean covers approximately 70% of the planet’s surface. This 
massive body of water encompasses different ecological niches, some of which are highly 
productive and prosperous in biodiversity, such as the sea-land interface and deep ocean 
thermal vent communities, others, such as the vast open ocean waters, possess limited 
production and are poor in biomass and diversity. Appeltans et al. (2012) enumerate a 
total of approximately 226.000 described marine eukaryotic species, and estimate that 
one-third to two-thirds of marine species are yet to describe (Appeltans et al., 2012).  
 
The quest for novel compounds of natural origin has been a persistent ambition for 
pharmaceutical research. Natural compounds are the main source of active ingredients in 
medicines, and in spite of modern pharmaceutical synthesis techniques, natural products 
are still the basis of almost half of all approved drugs. This success is in part due to the 
fact that natural products usually display high bioavailability, high affinity to target, as well 
as a minor loss of entropy when binding to proteins (Harvey, 2008). Indeed, the discovery 
of natural products in terrestrial fauna and flora has produced a grand diversity of 
bioactive compounds with the most varied chemistry and effects, as diverse as anticancer, 
anti-inflammatory, anti-parasitic, antiviral, analgesic, immunomodulator, anti-diabetic 
activity, amongst many others (Newman & Cragg, 2012).  
 
The focus is now turning also towards to the marine environment, where the broad and 
yet to explore biodiversity make promise of new chemical structures. In spite of this 
interest, the quest for marine natural products poses several challenges which limit its 
expansion; large and complex molecules, enhanced costs to collect and manipulate 
species, difficult culturability in laboratory conditions, the lack of technological tools and 
innovations and also environmental concerns (Bhatnagar & Kim, 2010). Approaches to 
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solving the problem of product availability may include the optimization of cultivation of 
target organisms with the goal of achieving mass-cultivation, either by adapting cultivation 
conditions (e.g., development of appropriate medium, adapting of growth conditions, novel 
technological tools) or by genetic engineering (Lang et al., 2005; C. Raghukumar, 2008). 
However, this is particularly hard to achieve with more complex organisms, such as many 
invertebrates, nonetheless, it is possibly more approachable when considering marine 
microorganisms. Marine microorganisms are solid candidates for the isolation of bioactive 
secondary metabolites, and as microbial cultivation and fermentation technologies 
advance in the future, there may be a substantial improvement in the availability of 
compounds from microbial origin and a lowering of the associated cost (Xiong et al.,, 
2013).  
The screening for novel bioactive compounds from marine sources can be undertaken 
by an array of procedures. These procedures must have as initial intent the choice of the 
target organism. Current screening strategies encompass conventional bioactivity guided 
screening, metagenomics, genomics, synthetic biology and combinatorial biosynthesis 
(Xiong et al., 2013).  
As a result of several marine compound screening initiatives, there are already a few 
drugs originated from marine compounds that have been approved for pharmaceutical 
use in humans or are currently under clinical trials (Martins et al., 2014). ET743 (also 
known as Trabectedin or Yondelis®) is a drug originated from the sponge Ecteinascidia 
turbinata and is currently approved in the EU for the treatment of advanced tissue 
sarcoma, as well as for the treatment of platinum-sensitive ovarian cancer in other 
countries (Newman & Cragg, 2014). Ziconotide (Prialt®) was approved by the FDA and 
EMA for use in chronic pain management, and is derived from the peptide ω-conotoxin 
isolated from the venom of a cone snail (Schmidtko et al., 2010). Another example of a 
marine drug currently in clinical use is cytarabine (Cytosar-U®, also known as arabinosyl 
cytosine), a synthetic pyramidine nucleoside based on spongothymidine, a nucleoside 
origined from the sponge Tethya crypta, is an FDA and EMA approved cytotoxic drug 
used in the treatment of several types of leukemia (Löwenberg et al., 2011; Mayer et al., 
2010). 
 
1.2.1. Marine fungi 
 
In the last few years, marine fungi have gained a growing interest from the scientific 
community as sources of bioactive compounds of biotechnological interest. This interest 
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rises from the fact that fungi produce secondary metabolites with potential concern in 
pharmacological and biological studies (Rateb & Ebel, 2011).  
Marine fungi differ from their terrestrial and freshwater counterparts in a critical factor. 
Fungi inhabiting the marine medium suffer a great influence from the seawater salinity, 
which is on average of 33 to 35 ppt. This poses several challenges for marine organisms, 
for they must adapt to several factors such as an increased pH, exposure to high sodium 
levels and alterations in internal water potential, and also low temperature, high 
hydrostatic pressure, oligotrophic nutrient conditions in deep-sea environments (Jennings, 
1983; Raghukumar, 2008). The latter is of critical importance, for marine fungi must 
present efficient osmoregulatory mechanisms to counter high salinity environments, as is 
the case of the observation of greater production of osmolytes such as glycerol when 
exposed to such conditions (Blomberg & Adler, 1992). The tolerance of salinity is also 
highly dependent on temperature (Lorenz & Molitoris, 1992). In actual fact, these factors 
are of such vital consequence that marine fungi geographic distribution is mostly 
influenced by sea temperature and salinity (Jones, 2000). 
Marine fungi can be effectively divided into two groups: obligate and facultative marine 
fungi. Those classified as obligate must by definition grow and sporulate exclusively in the 
marine environment, while those classified as facultative are commonly found in terrestrial 
or freshwater environments, however, are able to grow and sporulate in the marine 
medium due to a series of physiological adaptations (Kohlmeyer, 1974). However, the 
distinction between marine obligate and facultative is not always clear. Current studies 
have listed 530 obligate filamentous marine fungus species, inserted into 321 genera. A 
great majority of these species belong to the orders Ascomycota (424 species in 251 
genera), Halosphaeriales (126 species in 53 genera) and Deuteromycota (94 species in 
61 genera) and the remaining 12 species belonging to Basidiomycota (in 9 genera) (Jones 
et al., 2009). These numbers may however manifest a significant rise as research in this 
field increases and more recent molecular tools are applied. In spite of a potential 
escalation of the number of species, the actual number of marine fungi species culturable 
in laboratorial conditions is still extremely low (<1% of all estimated fungi biodiversity). 
This low culturability may be due to the artificial nature of the regularly used culture media 
for marine organisms, which may be lacking in essential nutrients (Alain & Querellou, 
2009). 
In an ecological perspective, marine fungi may be separated into various groups 
according to their habitat within the marine environment, such as oceanic, coastal, 
estuarine, deep-water, areniculous, or manglicolous marine fungi – different habitats in the 
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marine environment exert great influence on overall fungi diversity and adaptations (E. 
Jones, 2000). These fungi also happen to be associated to a large diversity of hosts, 
comprising several types of marine vertebrates and invertebrates, marine plants, algae, 
and marine microbial communities (Debbab et al., 2012; König et al., 2006; Raghukumar, 
2006; Rateb & Ebel, 2011). The sources of marine-derived fungi from which compounds 
have been extracted are portrayed in Figure 2.  
Fungi are known to produce secondary metabolites, which are small molecules that 
generally do not interfere in fungus’ normal development and growth (Fox & Howlett, 
2008). Marine-derived fungi strains are known to mostly produce polyketides, peptides, 
terpenoids, prenylated polyketides, alkaloids, shikimates, lipids and mixed biosynthesis 
compounds, which are in agreement with the secondary metabolites commonly produced 
by fungi (Rateb & Ebel, 2011; Swathi et al., 2013). 
There is currently one anticancer compound based on marine-derived fungi 
metabolites that has entered clinical trials. This alkaloid compound, plinabulin, is a 
modified structure based on (-)-phenylahistin, a metabolite of both terrestrial and marine 
fungi Aspergillus ustus (Hayashi et al., 2013; Kanoh et al., 1997).  
Figure 2 – Sources of fungi from which bioactive compounds have been isolated. Adapted 
from Rateb & Ebel (2011). 
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1.2.2. Fungi associate relationships as a source of bioactive compounds 
 
The total scale of marine fungi species is most probably greatly underrated. Current 
research has aimed at understanding marine fungi’s associations with other species, 
which has resulted in the collection of several novel species and strains (Passarini et al., 
2013; Wang et al., 2012). As previously mentioned, marine fungi are associated to several 
organisms, most importantly invertebrates, algae and plants. While in the case of 
invertebrates (e.g. corals, ascidians, holothurians, gorgonians and sponges) and algae, 
fungi usually interact by association, when concerning marine plants, marine fungi 
habitually act as endophytes (Debbab et al., 2012). An endophyte is a fungal or bacterial 
microorganism that colonizes a plant or algae either at an intra-cellular or inter-cellular 
level, this colonization takes place without an apparent pathogenicity towards the host and 
may occur during a part or the whole of the host’s life cycle (Tan & Zou, 2001). 
In the case of endophyte-host plant interaction, fungi secondary metabolites have been 
proven to contribute to the host’s survival and performance, by affecting factors such as 
chemical defense against predation, competitors and pathogens, growth rate, salt 
tolerance, photosynthesis and overall fitness, amongst others (Debbab et al., 2012). 
Whereas in fungal association to marine invertebrates, in particular sessile invertebrates, 
the role of fungi remains essentially unknown, however, fungi have been proposed as 
being able to improve the stability of the host skeleton, enable chemical defense against 
predators and competitors, parasitize pathogens, enhance nutrition and stimulate the 
host’s immune system (Selvin et al., 2010). This intricate relationship provided by 
association or endophytic behavior proves itself interesting for bioactive compound 
research since the colonization process and fungal-host interaction relies on chemical 
communication 
Sponges (phylum Porifera) represent some of oldest metazoans in existence. They are 
simply structured sessile invertebrates, which inhabit mostly marine and seldom 
freshwater systems. They are habitually attached to benthic substrates of the intertidal or 
deeper zones of tropical, temperate and polar waters (Thomas et al., 2010). Considering 
their relatively simple body structure and function, they heavily rely on chemical defense 
mechanisms to avoid predation and combat pathogens and competitors. Intense 
competition is in fact one of the main drivers for the production of toxic compounds, as the 
concentration of biomass is often overwhelming and space is limited in many ecological 
niches. Consequently, these compounds must reveal a surprising efficiency to exert their 
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effect as they are rapidly diluted in the seawater (Haefner, 2003). As a result, a great deal 
of attention was guided towards sponge secondary metabolites, and an extensive number 
of compounds have been extracted from these organisms. Several studies have attributed 
numerous pharmacological attributes to sponge metabolites, such as neuroprotective, 
antifungal, antibacterial, cyotoxic and antiparasitic activity (Kossuga et al., 2008; Qaralleh 
et al., 2010; Sasaki et al., 2011).  
Sponges are home to a massive microenvironment of associate microorganisms. 
These associated microorganisms are essentially of bacterial nature, however, recent 
research has shed some light into the actual diversity of symbiotic marine fungi attached 
to sponges. Höller et al. (2000) collected 16 sponge species from 6 different locations, 
from which they isolated 681 fungal strains. These fungal strains were predominantly 
representatives of ubiquitous genera, but marine genera were also observed (Holler et al., 
2000). In parallel, Morrison-Gardiner (2002) described the isolation of 208 fungal strains 
from marine sponges of tropical waters of Australia (Morrison-Gardiner, 2002). In similarity 
to the previous case, both ubiquitous and marine fungi genera were observed. The 
persistent observation of ubiquitous genera suggests that these fungi may be highly 
similar to their terrestrial counterparts, and may be in fact contaminants to the sponge. In 
fact, the exact role of marine fungi in their relationship with sponges remains unclear. 
However, the adaptations needed to endure marine conditions, vast marine fungal 
biodiversity and a prospective bioactive potential comparable to that of terrestrial fungi, 
make these fungi an undoubtedly interesting focus for the search of bioactive compounds 
(Taylor et al., 2007). Table 1 shows examples of the bioactivity of several compounds 
isolated from sponge-derived fungi.  
Gorgonian corals (phylum Cnidaria), also known as sea fans, are sessile colonial 
cnidarians which are mainly distributed in the tropics and sub-tropics. Much like sponges, 
due to their bodies and sessile nature, they are also exposed and vulnerable to predation 
and competition. While the need of sea fan for chemical defense and interaction makes 
these organisms themselves a prolific source of bioactive compounds (Rocha, Peixe, 
Gomes, & Calado, 2011), the focus on their microbial associates is beginning to arise. 
The interaction of fungi with sea fans is far less studied than that of other corals, in 
exception of the pathogenic relationship often observed, since sea fan communities are 
frequently attacked by violent fungal infections (Toledo-Hernández et al., 2013). However, 
there are a series of studies that have examined healthy sea fan populations and 
observed that healthy populations possess a more diverse array of fungi, which are 
considered residential (Toledo-Hernández et al., 2007). The association between non-
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pathogenic fungi and sea fans has been proposed to be of saprophytic nature, where the 
fungus consumes dead tissue from the coral (Kanoh et al., 1997). Meanwhile, reports of 
novel compounds derived from these sea fan associate fungi are rapidly increasing, and 
descriptions of antifouling, antibacterial, cytotoxic and other activities are already available 
(Bao et al., 2012; C. Li et al., 2011).  
 
Table 1 - Examples of compounds isolated from marine sponge-associated fungi and their bioactivity.	  
 
1.2.3.  Anticancer compounds of sponge and sea fan derived fungi origin 
 
Marine invertebrates have been on the spotlight of marine anticancer compound 
screening for a few decades. Sponges, gorgonians and soft corals have been the main 
targets for compound isolation (Bhatnagar & Kim, 2010), however, more recently, 
research has centered on discovering and isolating microorganism associates of these 
species and assessing compounds and extracts for anticancer activity.  
Bioactivity Fungus Sponge Metabolite Reference 
Antibacterial Aspergillus sp. Xestospongia testudinaria (−)-sydonic acid 
(D. Li et al., 
2012) 
 Aspergillus sp. Tethya aurantium Austalide R (Zhou et al., 2014) 
 Exophiala sp. Halichondria panacea Chlorohydroaspyrones A and B 
(D. Zhang, 
Yang, Kang, 
Choi, & Son, 
2008) 
Antifungal Penicillium spp. Tethya aurantium Nortryptoquivalin 
(Wiese, 
Ohlendorf, 
Blümel, 
Schmaljohann, & 
Imhoff, 2011) 
 Aspergillus insuetus Psammocinia sp. Insuetolides A, B and C 
(E. Cohen et al., 
2011) 
Cytotoxic 
Clonostachys 
sp. 
Unidentified sponge IB-01212 (Cruz et al., 2006) 
 Acremonium sp. Axinella sp. Efrapeptin E, F, Eα, G, H 
(Claudia M Boot 
et al., 2007; C. 
M. Boot, 
Tenney, 
Valeriote, & 
Crews, 2006) 
 Penicillium auratiogriseum Mycale plumose 
(S)-2,4-dihydroxy-1- 
butyl(4-hydroxy)-
benzoate 
(Xin et al., 2005) 
 Metarrhizium sp. Pseudoceratina purpurea Destruxin A and B2 
(Claudia M Boot 
et al., 2007) 
CHAPTER I 
 20 
The screening of extracts is often the first route to examine the potential in investing in 
the isolation of compounds. As an example of a sponge-associated fungus extract 
possessing anti-proliferative activity, the ethyl acetate extract of the fungus Eurotium 
cristatum obtained from the sponge Mycale sp. was shown to possess activity against 
three cancer cell lines: MCF-7 (breast adenocarcinoma), NCI-H460 (lung cancer), and 
A375-C5 (melanoma). The IC50 values were, respectively, 44.3, 45.5 and 71.3 µg/ml. 
Three compounds were isolated from this extract, of which 2-(2’, 3-epoxy-1’,3’-
heptadienyl)-6-hydroxy-5-(3-methyl-2-butenyl) benzaldehyde exhibited the most 
interesting cytotoxic activity in all three cell lines, however, the overall cytotoxic effect 
displayed by the crude extract quite possibly is also due to other unidentified compounds 
(Almeida et al., 2010). 
There are several examples of compounds isolated from sponge-associated fungi, as 
is the case of dankastatin C, a polyketide tyrosine derivative, isolated from the marine 
sponge-derived (Homaxinella sp.) fungus Gymnascella dankaliensis. This compound was 
a potent inhibitor of the P388 lymphocytic leukemia cell line, with an ED50 (half maximal 
effective concentration) of 57 ng/ml, having obtained an equivalent potency to that of the 
common chemotherapeutic drug 5-fluorouracil (Amagata et al., 2013). Another example is 
of epoxyphomalin A, isolated from the sponge-derived (Ectyplasia perox) fungus Phoma 
sp., which revealed a cytotoxicity at nanomolar concentrations against 12 human tumour 
cell lines, with IC50 values ranging from 0.010 µg/ml to 0.038 µg/ml (Mohamed et al., 
2009).  
While gorgonians or sea fans have been widely screened for cytotoxic compounds, 
their associate fungi counterparts have only very recently been approached in this matter. 
The following examples illustrate a few examples of compounds with different chemical 
composition and cytotoxic activity, originating from sea fan associate fungi.  
Nigrosporanene A, a cylohexene derivative isolated from the fungus Nigrospora sp. PSU-
F11 derived from the gorgonian sea fan Annella sp. presented an IC50 of 9.37 µg/ml in 
MCF-7 breast adenocarcinoma cells (Rukachaisirikul et al., 2010). Aspergillone A, a 
benzylazaphilone derivative isolated from the fungus Aspergillus sp. associated to the sea 
fan Dichotella gemmacea was found to demonstrate a potent cytotoxic effect against 
MCF-7 breast adenocarcinoma, A549 lung cancer and HL-60 human promyelocytic 
leukemia with the respective IC50 values of 25.0, 37.0 and 3.2 µg/ml (Shao et al., 2011). 
Asperterrestide A, a cyclic tetrapeptide, was isolated from the fungus Aspergillus terreus 
that was isolated from the tissue of the sea fan Echinogorgia aurantiaca, exhibited a 
cytotoxic effect against two human leukemia cell lines, U937 leukemic monocyte 
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lymphoma and MOLT4 acute lymphoblastic leukemia (IC50 of 6.4 and 6.2 µM, 
respectively) (He et al., 2013). Oxalicumones D and E, two dihydrothiophene-condensed 
chromones, were isolated from the fungus Penicillium oxalicum SCSGAF 0023 associated 
to the sea fan Muricella flexuosa. Oxalicumone E demonstrated a strong cytotoxic activity 
against a panel of eight cancer cell lines (H1975, U937, K562, BGC823, MOLT4, MCF-7, 
HL60 and Huh-7) with IC50 values ranging from 1.36 to 8.80 µM. Oxalicumone D, 
however, exhibited a cytotoxic effect against BGC823 gastric cancer and MOLT4 acute 
lymphoblastic leukemia cell lines with an IC50 of 10.10 and 5.74 µM, respectively (Bao et 
al., 2014). 
 
1.2.4.  Neosartorya genus 
 
Neosartorya is a genus of fungi that is common in the terrestrial environment, where it 
has been described as occurring in the soil, organic materials, air, food and human 
habitations but also in the marine environment (Yaguchi et al., 2010). The Neosartorya 
genus belongs to the phylum Ascomycota and species of this genus are a telemorphic 
(i.e., sexual reproductive) stage of the Aspergillus section Fumigati. Neosartorya species 
are known to produce an asexual state with conidiospores and a sexual state with 
ascospores (Frisvad et al., 2008). Although some Neosartorya species have been 
identified as the cause of several human pathologies, such as invasive aspergillosis, 
endocarditis, and osteomyelitis (Peláez et al., 2013; Summerbell et al., 1992), recent 
studies have approached these species as a source of interesting bioactive compounds 
with potential application in human health (Eamvijarn et al., 2013; Gomes et al., 2014; 
Padhye et al., 1994).  
Several terrestrial strains of Neosartorya have yielded interesting cytotoxic compounds, 
for instance, the pyrroloindole sesquiterpenoid fischerindoline, isolated from Neosartorya 
pseudofischeri CBS 404.67. This compound presented moderate cytotoxic activity in five 
human cancer cell lines (A549, Hs683, MCF-7, SKMEL-28 and U373) and one murine 
melanoma cell line (B16F10), with IC50 values ranging from 25 to 37 µM (Masi et al., 
2013). Another example is the indoloazepinone deriviative sartorymensin, isolated from 
Neosartorya siamensis KUFC 6349, which exhibited cytotoxic activity against five human 
cancer cell lines (U373, Hs683, A549, MCF-7 and SKMEL-28) with IC50 values that 
ranged from 39 to 73 µM (Buttachon et al., 2012). 
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More recently, marine strains of Neosartorya have been subjected to isolation of 
compounds and subsequent screening of cytotoxic activity. In a study by Eamvijarn et al. 
(2013) several compounds were isolated from Neosartorya tsunodae (KUFC 9213), 
Neosartorya fischeri (KUFC 6344) and Neosartorya laciniosa (KUFC 7896). The isolated 
compounds, 13-oxofumitremorgin B, sartorypyrone A, aszonapyrone A and sartorypyrone 
B, presented low to high cytotoxic activity (GI50 values ranging from 123.3 to 10.2 µM) 
against MCF-7, NCI-H460 and A375-C5 (Eamvijarn et al., 2013).  
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2.1. Manuscript 
 
Abstract 
 
Aim: To evaluate the in vitro anticancer activity of crude ethyl acetate extracts of 
the culture of four marine-derived fungi Aspergillus similanensis KUFA 0013 
(E1), Neosartorya paulistensis KUFC 7897 (E2), Neosartorya siamensis KUFA 
0017 (E4) and Talaromyces trachyspermus KUFC 0021 (E3) on a panel of 
seven human cancer cell lines.  
Methods and results: Effects on cell proliferation, induction of DNA damage 
and cell death were assessed by MTT and clonogenic assay, comet assay and 
nuclear condensation assay, respectively. The proliferation of HepG2, HCT116 
and A375 cells decreased after 48 h incubation with the extracts from N. 
paulistensis and N. siamensis. The anti-proliferative effect was confirmed by 
MTT assay, morphologic alterations and by clonogenic assay. Both extracts also 
induced cell death in HepG2 and HCT116 cells. Doxorubicin was used as a 
positive control and showed in vitro anticancer activity.  
Conclusions: This study demonstrated for the first time that extracts from N. 
paulistensis and N. siamensis have selective anti-proliferative and cell death 
activity in HepG2, HCT16 and A375 cells.  
Significance and Impact of the Study: The bioactivity of these extracts 
suggests a potential for biotechnological applications, and substantiates that 
both should be further considered for identification of compounds with anticancer 
activity and elucidation about the molecular targets and signal transduction 
pathways involved.  
 
Keywords:  
Marine-derived fungi; anti-proliferative; cell death; cytotoxicity; anticancer 
activity; human cancer cell lines. 
 
Abbreviations:  
Doxorubicin (Dox); Strand breaks (SB); Dimethylsulphoxide (DMSO); Aspergillus 
similanensis extract (E1); Neosartorya paulistensis extract (E2); Talaromyces 
trachyspermus extract (E3); Neosartorya siamensis extract (E4).
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Introduction 
 
Cancer is one of the main causes of death worldwide. In the following decades, the 
number of people with cancer will continue to increase, largely due to lifestyle, nutrition and 
environmental conditions in developed countries (Marmot et al. 2007; Veer and Kampman 
2007; Jemal et al. 2011). During cancer development, cells acquire several genetic and 
epigenetic changes. These changes result in the progressive acquisition of biological 
characteristics such as sustained proliferative signaling, insensitivity to growth suppressors, 
evading apoptosis, increasing genomic instability, activating mobility, invasion, metastasis 
and angiogenesis that may thus evolve into a malignant phenotype (Hanahan and Weinberg 
2011).  
Apoptosis is a mechanism of programmed cell death essential to maintain tissue 
homeostasis since it is a genetically determined elimination of abnormal or damaged cells. 
Apoptosis occurs by a programmed pathway and does not involve inflammation (Portt et al. 
2011). Its dysfunction is associated with cancer development, and several strategies have 
been used to reactivate apoptosis in cancer cells for eliminating them. Apoptotic cells 
develop typical morphological changes such as shrinkage, membrane blebbing, chromatin 
condensation, nuclear fragmentation and the formation of apoptotic bodies, all of which are 
features that allow its identification (Nguyen et al. 2013).  
Advances in cancer biology knowledge have allowed the development of new treatment 
strategies, including new anticancer drugs that may act in one or more of the hallmarks 
described above. In fact, compounds that reactivate cell death and/or decrease proliferative 
ability in cancer cells show a potential anticancer activity. However, most of the anticancer 
drugs currently used give rise to undesirable side effects. One such example is doxorubicin 
(Dox), an anticancer drug used in the treatment of a wide range of cancers, and known to 
induce severe side effects such as cardiotoxicity and tumor drug-resistance (Carvalho et al. 
2009). Therefore, new anticancer drugs with more efficiency and ability to mitigate side 
effects are in need. 
It is interesting to note that more than 50% of the drugs used in cancer treatment are from 
natural origin, mainly from plant sources (Sithranga Boopathy and Kathiresan 2010). 
Nonetheless, the marine environment represents about 95% of the world’s biosphere and is 
an important source of bioactive compounds to be explored (Munro et al. 1999; Jimeno et al. 
2004). Marine organisms have been used as sources of folk medicine since ancient times, 
for instance, for the treatment of gout, cough, wounds, goiter and other illnesses (Sithranga 
Boopathy and Kathiresan 2010).  On the other hand the discovery of penicillin in 1928 by 
Alexander Fleming greatly increased the interest in the use of microorganisms as a source 
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of bioactive compounds, in particular of fungi (Debbab et al. 2010). Marine fungi remained 
until recently much less studied than terrestrial fungi, nevertheless, novel metabolites have 
been found in marine fungi that greatly differ from those found in terrestrial counterparts 
(Sithranga Boopathy and Kathiresan 2010). The production of secondary metabolites by 
marine fungi can be influenced by the combination of the marine environment’s unique 
conditions such as variations in temperature, light, water current, salinity, nutrient 
availability, all of which create a highly competitive environment and thus force marine 
organisms to evolve complex chemical adaptations, many of which developed under a 
symbiotic relationship with other species (Simmons et al. 2005; Tohme et al. 2011). In fact, 
recent research has exploited these symbiotic relationships in marine ecosystems as a 
source for bioactive compounds. This is particularly pertinent when analyzing the case of 
microbe-sponge relationships, and whereas sponges are known to be notable sources for 
bioactive compounds, where origin has also been attributed to the sponge’s microbial 
associates, namely fungi and bacteria (Thomas et al. 2010). Furthermore, compounds are 
frequently produced as a chemical manner of defense by many marine organisms, and are 
released into the water and thus diluted. Consequently, these compounds must be 
extremely efficient in order to produce their effect in spite of their dilution in the water. 
Hence, these metabolites seem to have interest as novel lead structures for the synthesis of 
new bioactive compounds (Haefner 2003; Debbab et al. 2010; Tohme et al. 2011).  
In regard to biological activity, several metabolites produced by marine-derived fungi 
have been reported as antibacterial, antiviral, antifungal, antioxidant and anticancer agents 
(Shen et al. 2009; Tsukada et al. 2011; Arasu et al. 2013; Pejin et al. 2013; Qi et al. 2013; 
Gomes et al. 2014; Henriquez et al. 2014). Notwithstanding the increasing interest in these 
bioactive compounds, there is frequently an effective difficulty in extracting these 
compounds from nature since their source organisms are often hard to reproduce and 
manipulate in laboratorial conditions, limiting their availability and use. Interestingly, some 
marine fungi may grow efficiently under laboratory conditions, which may therefore enable 
the use of biotechnological tools for a massive production of the compounds of interest (Kjer 
et al. 2010; Cai et al. 2011). In summary, marine-derived fungi seem to be good candidates 
as a source of new bioactive compounds, thus making them a pivotal part of the emergent 
marine biotechnology applications.  
Our present purpose was to assess the in vitro anticancer activity of crude ethyl acetate 
extracts of the sponge-derived fungi A. similanensis KUFA 0013 (E1), N. paulistensis KUFC 
7897 (E2) and T. trachyspermus KUFC 0021 (E3), and the sea fan-derived fungi N. 
siamensis KUFA 0017 (E4), on a panel of seven human cancer cell lines, namely, colorectal 
carcinoma (HT29, HCT116), hepatocellular carcinoma (HepG2), breast adenocarcinoma 
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(MCF-7), malignant melanoma (A375), non-small cell lung carcinoma (A549) and 
glioblastoma (U251) cells.  
 
 Materials and methods 
 
Chemicals 
 
Doxorubicin, DMEM, MEM, RPMI-1640, sodium pyruvate, sodium bicarbonate, N-(2-
hydroxyethyl)piperazine-N’-(2-ethanesulfonic acid) (HEPES), penicillin/streptomycin, trypsin 
solution, 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) and 4,6-
diamidino-2-phenylindole (DAPI) were purchased from Sigma-Aldrich (St. Louis, MO, USA). 
Fetal bovine serum (FBS) was purchased from Biochrom KG (Berlin, Germany). All other 
reagents and chemicals used were of analytical grade.  
 
Fungal material 
 
Aspergillus similanensis (KUFA 0013) was isolated from the marine sponge Rhabdermia 
sp., which was collected from the coral reef of the Similan Island in the Andaman Sea, off 
the coast of Phanga Province, Thailand, by scuba diving at 10 m depth, in April 2010. The 
fungus was identified by one of us (T. Dethoup) by morphological features, including 
characteristic of ascospores, conidiogenesis and colonies and by sequence analysis of the 
calmodulin gene (Glass and Donaldson 1995). The pure cultures were deposited as KUFA 
0013 at the Department of Plant Pathology, Faculty of Agriculture, Kasetsart University, 
Bangkok, Thailand (Prompanya et al. 2014). 
N. paulistensis (KUFC 7897) was isolated from the marine sponge Chondrilla 
australiensis which was collected from Mu Kho Lan Beach, Chonburi Province, Thailand in 
May 2010. The fungus was identified by Prof. Leka Manoch (Department of Plant Pathology, 
Kasetsart University, Bangkok, Thailand), and the identification was supported by sequence 
analysis of the β-tubulin gene (Glass and Donaldson 1995) and the pure cultures were 
deposited as KUFC 7897 at the Kasetsart University Fungal Collection, Department of Plant 
Pathology, Faculty of Agriculture, Kasetsart University, Bangkok, Thailand, and as MMERU 
02 at the Microbes Marine Environment Research Unit, Division of Environmental Science, 
Faculty of Science, Ramkhamhaeng University, Bangkok, Thailand (Gomes et al. 2014). 
T. trachyspermus (KUFC 0021) was isolated from the marine sponge Clathria reianwardii, 
which was collected from the coral reef at Kram Island, Chonburi Province, Thailand, by 
scuba diving at 10 m depth, in September 2011. The fungus was identified as Talaromyces 
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trachyspermus and the pure cultures were deposited as KUFC 0021 at the Kasetsart 
University Fungal Collection, Department of Plant Pathology, Faculty of Agriculture, 
Kasetsart University, Bangkok,Thailand (Kuml et al. 2014). 
N. siamensis (KUFA 0017) was isolated from sea fan (Rumphella sp.), collected from the 
coral reef at Similan island, PhangNga province, Southern Thailand, by scuba diving at 10 m 
depth, in April 2010. Briefly, the sea fan tissue was cut into a piece of 0.5 cm x 0.5 cm, 
placed on the malt extract agar (MEA) with 70% sea water and incubated for 28ºC for 7 
days. The fungus was identified by one of us (T. Dethoup) by morphological features, 
including the characteristic of ascospores and colonies, and by sequence analysis of the β-
tubulin gene (Glass and Donaldson 1995). The pure cultures were deposited as KUFA0017 
at Kasetsart University Fungal Collection, Department of Plant Pathology, Faculty of 
Agriculture, Kasetsart University, Bangkok, Thailand. 
 
Preparation of crude ethyl acetate extracts from marine-derived fungi 
 
A. similanensis (KUFA 0013), N. paulistensis (KUFC 7897) and T. trachyspermus (KUFA 
0021) were cultured as described by Prompanya et al. (2014), Gomes et al. (2014) and 
Kumla et al. (2014), respectively. Briefly, the fungi were cultured for one or two week in 90 
mm Petri dishes with 25 ml of malt extract agar (MEA) with 70% sea water. Erlenmeyer 
flasks of 1000 ml, containing rice and water, were inoculated with mycelia plugs of the fungi 
and incubated at 28ºC for 30 days after which the moldy rice was macerated in ethyl acetate 
for seven or ten days and filtered. The two layers were separated and the ethyl acetate 
solution was concentrated at a reduced pressure to yield 97, 51 and 102 g of the crude ethyl 
acetate extract, respectively (Kuml et al. 2014; Prompanya et al. 2014). 
N. siamensis (KUFA 0017) was cultured for one week in five 90 mm Petri dishes with 25 
ml of potato dextrose agar per dish. Thirty-five 1000 ml Erlenmeyer flasks containing 200 g 
of rice and 100 ml of water were autoclaved at 121ºC for 15 min, and then inoculated with 
ten mycelium plugs of the fungus. The culture was incubated at 28ºC for thirty days. To each 
flask with the mouldy rice was added 500 ml of ethyl acetate and the content was left to 
macerate for seven days. The content of the flasks was filtered by filter paper and the filtrate 
was evaporated under reduced pressure to give 1000 ml of the solution and then anhydrous 
sodium sulphate was added and filtered. The ethyl acetate solution was evaporated under 
reduced pressure to give 5 g of dark brown viscous mass of a crude ethyl acetate extract. 
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Cell culture  
 
Seven human cancer cell lines were used to assess anti-proliferative activity. HT29 and 
HCT116 (colorectal carcinoma) were kindly provided by Prof. Carmen Jerónimo from IPO, 
Porto. HepG2 cells were kindly provided by Prof. Rosário Martins from CIIMAR, Porto. MCF-
7, A375, A549 and U251 cells were obtained from European Collection of Cell Cultures 
(ECACC). Human cancer cell lines were maintained as monolayer cultures in DMEM (HT29, 
A375 and A549), MEM (HepG2, MCF-7 and U251) and RPMI (HCT116) supplemented with 
10% FBS and 1% of antibiotic solution (100 U ml-1 penicillin and 100 µg ml-1 streptomycin), 
0.1 mM sodium pyruvate and 10 mM HEPES under an atmosphere of 5% CO2 at 37ºC. 
Cells were trypsinised when nearly confluent.  
Stock solutions of Dox and crude ethyl acetate extracts of marine fungi were prepared in 
DMSO and aliquots kept at -20ºC. The final concentration of DMSO in the medium was 
<0.5% (v/v). The controls received only DMSO. All the cells were incubated with extracts 
and Dox dissolved in RPMI just before use, in order to maintain the same conditions for all 
cell lines. 
 
MTT reduction assay 
 
To evaluate effects of the crude ethyl acetate extracts on cell viability/proliferation, cells 
were plated in 96-multiwell culture plates at a density of 0.8x104 to 1x104 cells/well. Twenty-
four hours after plating, the medium was discarded and fresh medium containing extracts of 
marine-derived fungi at different concentrations (0.1 - 500 µg ml-1) and Dox at (0.001 - 10 
µM) as positive control, as well as 0.5% DMSO as negative control was added. After 48 h 
incubation with extracts, MTT was added at a final concentration of 0.5 mg ml-1 and 
incubated for 2 h. Then, the medium was removed, and the formazan crystals were 
dissolved in a DMSO:ethanol solution (1:1) (v/v). Absorbance was measured at 570 nm in a 
microplate reader (Multiskan EX, Labsystems, USA). The MTT colorimetric assay is based 
upon mitochondrial conversion of tetrazolium salt (MTT) into formazan crystals, and thus 
alterations in the number of viable cells can be detected by measuring formazan crystals 
optical density (Ramos et al. 2008; Xavier et al. 2009). IC50 corresponds to the concentration 
of extract or Dox that decreases the number of viable cells by 50%. In this case, the 
absorbance in the control at 48 h corresponds to 100% viability. The IC50 values were 
determined using GraphPad Prism v5.0 software (GraphPad Software, La Jolla, CA, USA). 
To evaluate the effect on cell proliferation, the absorbance at the beginning of incubation (t = 
0 h) was subtracted from all the experimental conditions used, including the control at 48 h. 
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Therefore, negative values can be interpreted as direct cytotoxic effects of extracts while 
positive values (between 0 and 100%) can be interpreted as inhibition of cell proliferation. 
This variant of the MTT assay allows a rapid and simple discrimination between inhibition of 
cell proliferation and cell death (Kiesslich et al. 2013). The results were expressed as the 
percentage of cell viability/proliferation relative to control (untreated cells) of at least six 
independent experiments; each one was carried out in duplicate. For the following assays, 
only fungi extracts that presented an IC50 equal or less than the arbitrary cut-off threshold of 
200 µg ml-1 and without direct cytotoxic effects were used. 
 
Clonogenic assay  
 
To study the effect of the extracts of marine-derived fungi on the proliferation of 
clonogenic cells, cells were plated (0.1x106 cells/well) in 24-multiwell culture plates and 
treated with extracts or Dox (IC50). After a 48 h treatment, survival cells were trypsinized, 
counted and plated in 6-multiwell culture plates at 200 cells/well with fresh medium. After 10 
days of culture, colonies were fixed, stained with crystal violet (0.05% w/v) for 30 min and 
washed with water. Colonies containing more than 50 individual cells were counted using a 
stereomicroscope (Leica, ZOOM 2000). Plating efficiencies (PE) were calculated from the 
ratio between the number of colonies counted and the number of cells plated. The surviving 
fraction (SF) was calculated using the formula: SF = 100 × [PE of treated cells ÷ PE of 
control] (Munshi et al. 2005; Zips et al. 2005; Franken et al. 2006; Haloom et al. 2011; 
Rafehi et al. 2011). Results were expressed as the surviving fraction relative to control (cells 
treated with 0.5% DMSO).  
 
Comet assay 
 
To investigate the genotoxic effect of the tested fungal, cells were plated (0.1x106 
cells/well) in 24-multiwell culture plates. Twenty-four hours after plating, cells were incubated 
with the extracts of marine-derived fungi  (IC50) for 4, 24 and 48 h and DNA damage (strand 
breaks and alkali-labile sites) was assessed by the alkaline version of the single cell gel 
electrophoresis (comet) assay (Collins et al. 2008; Ramos et al. 2010). In short, after 
treatment cells were trypsinized, washed, centrifuged, and the pellet suspended in low 
melting point agarose and about 2×104 cells/gel were placed on a slide pre-coated with 1% 
normal melting point agarose. Slides were placed in lysis solution (2.5 M NaCl, 100 mM 
Na2EDTA, 10 mM Tris Base, pH 10 plus 1% Triton X-100) for 1 h at 4ºC, and then placed in 
a horizontal electrophoresis chamber with a buffered solution (300 mM NaOH, 1 mM 
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Na2EDTA, pH >13), for 40 min at 4ºC, for the DNA to unwind. The electrophoresis was run 
for 20 min at 21V the slides were washed twice with PBS and dried at room temperature. 
For the analysis of the comet images, the slides were stained with DAPI solution (1 µg ml-1) 
and visualized in a fluorescence microscope (Olympus IX71). Images were registered and 
studied with the image analysis software CometScore® (CometScore, TriTek Corp.), for 
quantifying the percentage of tail intensity. At least 100 simply randomly selected cells were 
analyzed per sample. 
 
Nuclear condensation assay 
 
To evaluate the ability of the extracts of marine-derived fungi to induce cell death, cells 
were plated (0.1x106 cells/well) in 24-multiwell culture plates. After cell adhesion, cells were 
treated with extracts or Dox (IC50) for 48 h and nuclear condensation was assessed by 
observation in the mentioned fluorescence microscope. Briefly, both adherent and non-
adherent cells were collected, washed, centrifuged, fixed with 4% (w/v) paraformaldehyde in 
PBS for 20 min at 37ºC, and then attached into a polylysine-treated slide using a Cytospin 
Cytocentrifuge (Thermo Scientific, USA). Once dried, slides were incubated with DAPI (1 µg 
ml-1) for nuclei staining. The percentage of cells with condensed nuclei was calculated from 
the ratio between cells with nuclear condensation and total number of cells (nuclei staining 
with DAPI). More than 300 cells were counted per sample.  
 
Statistical analysis 
 
Results were expressed as mean ± SD from at least 3 independent experiments. The 
GraphPad Prism 5.0 software (GraphPad Software, La Jolla, CA, USA) was used for 
inferential statistics. Eventual significant differences (P≤0.05) were evaluated by one-way 
ANOVA, followed by the post-hoc Newman-Keuls multiple comparison test or Dunnett’s test 
as appropriate. In specific cases Student t-test was used as described. Data from the MTT 
assay were analysed for normal distribution using the D’Agostino-Pearson omnibus test. For 
the remaining data, normal distribution was not tested due to low “n”, and was assumed to 
occur, which is consistent with the normal behaviour of cell culture responses as observed in 
similar published studies.  
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Results 
 
Evaluation of the effect of the extracts of marine-derived fungi on cell viability and 
proliferation by MTT reduction assay in cancer cells 
 
In order to test the effects of the extracts of four marine-derived fungi on cell viability and 
proliferation, seven human cancer cell lines, HT29, HCT116, HepG2, MCF-7, A375, A549 
and U251 were used. The assay was performed on exponentially growing cells, as 
previously determined (data not shown). Each cell line was incubated for 48 h with extracts 
at different concentrations (0.1-500 µg ml-1) and then cell viability and proliferation was 
assessed by MTT assay. Doxorubicin was tested in parallel over a concentration range 
(0.001-10 µM), corresponding to (5.8x10-4 - 5.8 µg ml-1), as a positive control. The IC50 
(concentration of extract or Dox that reduces the number of viable cells by 50 %) for each 
cell line was calculated from the dose-response curves. The values of the IC50 are 
summarized in Table 1. Extracts E2 and E4 significantly decreased the number of viable 
cells in HepG2, HCT116 and A375 cells. Both extracts showed similar IC50 values for HepG2 
cells. Regarding HCT116 and A375 cells, extract E4 showed a lower IC50 value (124 and 
150 µg ml-1, respectively) when compared to extract E2 (165 and 184 µg ml-1). The extracts 
E1 and E3 had an IC50 higher than the cut-off level of 200 µg ml-1 in all tested cell lines, and 
therefore they were not used in the following experiments. Dox decreased cell viability in all 
tested cell lines and the related IC50 values ranged from 0.11 µM to 1.55 µM (corresponding 
to 0.06 – 0.9 µg ml-1) (Table 1).   
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Table 1 – Determination of IC50 values (concentration that inhibits the number of viable cells in 50%) 
of four extracts in seven cells lines. Doxorubicin was used as a positive control. IC50 values are the 
mean at least 6 independent experiment each in duplicate. 
 
 
In order to evaluate the effects of the extracts of marine-derived fungi on cell proliferation, 
the number of viable cells at the beginning of experiment (when extracts were added, t = 0 
h), assessed by MTT, were subtracted to the number of viable cells at the end of experiment 
(t = 48 h). The results were represented as percentage of cell proliferation relative to control 
(cells with 0.5% DMSO). Values between 0 and 100% can be interpreted as anti-proliferative 
effects, while negative values can be a direct cytotoxic effect. We observed that all cell lines, 
when treated only with 0.5% DMSO (negative control), grew significantly between the 
beginning (t = 0 h) and the end of the incubation (t = 48 h) (data not shown). The results 
showed that extracts E2 and E4 decreased cell proliferation in a concentration-dependent 
manner in HepG2, HCT116 and A375 cells (Figure 1). The anti-proliferative effect of both 
extracts was higher in HCT116 and A375 cells. The extract E2 at 100 µg ml-1 significantly 
decreased proliferation of HCT116 and A375 cells by 43% and 25%, respectively relative to 
control (Figure 1A). At the same concentration, extract E4 significantly decreased 
proliferation of HCT116 and A375 cells by 72% and 60%, respectively (Figure 1B). In the 
MTT assay, extract E4 was more active in the cells lines tested. For concentrations higher 
than 200 µg ml-1, both extracts showed a direct cytotoxic effect in HepG2, HCT116 and 
A375 cells. Dox decreased cell proliferation in a concentration-dependent manner in all cell 
lines tested. At 1 and 10 µM, Dox exhibited a direct cytotoxic effect in HepG2, HCT116 and 
A375 cells (Figure 1C).  
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Figure 1. Dose-response effects of extracts E2 (A), E4 (B) and doxorubicin (C) on cell 
viability/proliferation in HepG2, HCT116 and A375 cells after 48 h, evaluated by MTT assay. Results 
are expressed as mean ± SD of at least six independent experiments, each made in duplicate. 
Significant differences (* P≤0.05; ** P≤0.01 and *** P≤0.001) among groups per situation of exposure 
were tested by one-way ANOVA, followed by the post-hoc Newman-Keuls multiple comparison test.   
 
 
To select the extracts and cell lines to use in the following experiments, two aspects were 
considered: 1) extracts should inhibit cell proliferation without significant direct cytotoxic 
effects; and 2) the IC50 value of the extract should be lower than 200 µg ml-1. Having met 
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these two criteria, extracts E2 and E4 were selected and the anti-proliferative and pro-cell 
death effects were evaluated in HepG2, HCT116 and A375 cells. 
The anti-proliferative effect of extracts E2, E4 and Dox in HepG2, HCT116 and A375 was 
also confirmed by a decrease of cell density and also by structural alterations, such as 
rounded and detached cells as observed in a phase contrast microscope (Figure 2).  
 
 
 
Figure 2. Morphology of HepG2 cells under phase contrast, after 48 h incubation with A) 0.5 % of 
DMSO, B) Dox, C) extract E2, and D) extract E4, all three at IC50. Situation A) represents control 
cells, with normal morphology. In B), C) and D) arrows indicate rounded and detaching cells. Scale 
bar = 10 µm. 
 
 
Evaluation of the effect of the extracts of marine-derived fungi on reproductive viability by 
the clonogenic assay 
 
To evaluate the long-term anti-proliferative effects of the extracts, cells were pre-treated 
for 48 h with the extracts (IC50) and then survival cells were allowed to grow for 10 days in 
fresh medium without extracts. Results from the clonogenic survival assay showed that 
extract E2 significantly decreased the proliferative ability of a single cell to form a viable 
colony in HepG2, HCT116 and A375 cells (Figure 3). Extract E4 significantly reduced the 
number of colonies in HepG2 and HCT116 cells when compared with control (cells pre-
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treated with 0.5% DMSO) (Figure 3A and 3B). Meanwhile, no significant results were 
observed in A375 cells (Figure 3C). Cells pre-treated with Dox did not show ability to 
proliferate and form colonies.  
 
 
Figure 3. Clonogenic survival of HepG2 (A), HCT116 (B) and A375 (C) cells after pre-treatment with 
extracts E2, E4 and Dox (all three at IC50) for 48 h, followed by 10 days in fresh medium. Results are 
expressed as mean ± SD of at least three independent experiments. Significant differences (* P≤0.05; 
** P≤0.01 and *** P≤0.001) when compared with control cells were evaluated by one-way ANOVA, 
followed by the post-hoc Dunnett’s test. D) Representative images of clonogenic assay in HepG2 
cells after pre-treatment with a) 0.5 % of DMSO, b) extracts E2, c) extract E4 and d) Dox at IC50, 
showing a decrease of the number of colonies formed relative to control (a). 
 
 
Evaluation of the effect of the extracts of marine-derived fungi on DNA damage by the comet 
assay 
 
To assess the genotoxic effect of the extracts, cells were incubated with them at an IC50 
concentration for 4, 24 and 48 h, and DNA damage (SBs and alkali-labile sites) was 
assessed by the comet assay. Results were expressed as the percentage of DNA in tail. At 
4 and 24 h of incubation, none of the extracts at the tested concentrations induced DNA 
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damage in HepG2, HCT116 or A375 cells (data not shown). However, after incubation for 48 
h, extract E2 significantly increased by 16% the extent of DNA damage in the HepG2 cells 
(see white bars, Figure 4), when compared with control cells (treated with 0.5% DMSO). No 
effect was observed in HCT116 (grey bars) and A375 (black bars) cells when treated with 
extract E2. Moreover, extract E4 did not induce DNA damage detectable by comet assay at 
any of the tested experimental conditions. However, at 48 h, Dox evidenced a significant 
increase of DNA damage in HCT116 (by 25%) and A375 (by 9%) cells, when compared to 
the control (Figure 4). 
 
 
Figure 4. Effect of extracts E2, E4 and Dox (all three at IC50) on DNA damage (SBs and alkali-labile 
sites) after 48 h in HepG2, HCT116 and A375 cells, assessed by comet assay. Values are mean ± 
SD of at least three independent experiments. Significant differences (* P≤0.05) when compared with 
control cells were judged by one-way ANOVA, followed by the post-hoc Dunnett’s test. Additionally, a 
Student’s t-test was selectively used to access significant differences in HepG2 (E2) and A375 (Dox) 
in relation to the respective control. 
 
 
Evaluation of the effects of the extracts of marine-derived fungi on cell death by the nuclear 
condensation assay 
 
Since the anti-proliferative effects of the extracts could be due to cell death, we evaluated 
nuclear condensation after 48 h cell incubation with extracts (at IC50). As shown in Figure 5, 
extract E2 significantly induced nuclear condensation in HepG2 (Figure 5A) and HCT116 
cells (Figure 5B). The number of cells with condensed nuclei was increased by 9% in 
HepG2 and 24% in HCT116 cells. Extract E4 also induced an increase of nuclear 
condensation, by 9% in HepG2 and 16% in HCT116 cells. Dox induced nuclear 
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condensation too, by 10% in HepG2 and by 8% in A375 cells. However, none of the tested 
extracts induced an increase of cells with nuclear condensation in A375 cells (data not 
shown). The HCT116 cells were the most sensitive to cell death induction by the extracts, 
being extract E2 the most effective against this cancer cell line. 
 
 
 
Figure 5. Effect of extracts E2, E4 and Dox (all three at IC50) on the induction of nuclear chromatin 
condensation in HepG2 (A) and HCT116 cells (B) by the nuclear condensation assay after 48 h of 
incubation. Values are mean ± SD of at least three independent experiments. Significant differences 
(** P≤0.01 and *** P≤0.001) when compared with control cells were determined by one-way ANOVA, 
followed by the post-hoc Dunnett’s test. C) Representative images of nuclear condensation in 
HCT116 cells after exposure to a) 0.5 % of DMSO, b) extracts E2, c) extract E4 and d) Dox at IC50. 
Scale bar = 100 µm. Nuclear condensation (arrow). 
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Discussion 
 
Marine-derived fungi biosynthesize a vast range of secondary metabolites with complex 
and unique structures (Bhakuni and Rawat 2005). However, very little is known about the 
biological activity of the extracts and compounds of these fungi. In this study, we 
investigated the in vitro anticancer activity of crude ethyl acetate extracts obtained from four 
marine-derived fungi A. similanensis (E1), N. paulistensis (E2), N. siamensis (E4) and T. 
trachyspermus (E3) on seven human cancer cell lines. The crude ethyl acetate extracts from 
N. paulistensis and N. siamensis, at concentrations that did not induce direct cytotoxicity, 
inhibited proliferation in HepG2, HCT116 and A375 cells, and caused cell death in HepG2 
and HCT116 cells.  
To the best of our knowledge this is the first report on the in vitro anticancer activity of 
marine-derived fungi N. paulistensis (KUFC 7897) and N. siamensis (KUFA 0017). 
(Buttachon et al. 2012) described that some isolated compounds from the culture of the 
strain of N. siamensis (KUFC 6349) isolated from soil, viz. sartorymesin, had anti-
proliferative activity in U373 and Hs683 glioblastoma, A549 lung cancer, MCF-7 breast 
cancer and SK-MEL-28 melanoma cell lines.  
In this study we showed that extracts E2 and E4 decrease the number of viable cells, with 
an IC50 lower than 200 µg ml-1 in HCT116, A375 and HepG2 cells. Extracts E1 and E3 
exhibited lower activities, with an IC50 higher than 200 µg ml-1 in all of the tested cell lines. 
The effect of the extracts on cell proliferation was also determined by the MTT assay where 
positive values imply that the extracts have an anti-proliferative effect that is maybe due to 
cytotoxic and/or cytostatic effects. Negative values suggest that the number of viable cells 
after a 48 h exposure to extracts was less than the number of viable cells at the incubation 
beginning. This can occur due to a direct and short-term cytotoxic effect of the extracts, 
which may in turn indicate necrotic cell death (Kiesslich et al. 2013). Extracts E2 and E4 
decreased cell proliferation in a dose-dependent manner and at concentrations greater than 
200 µg ml-1, exhibited a direct cytotoxic effect in HepG2, HCT116 and A375 cells. Some 
authors refer that intense insults (exposure to high concentrations) are able to induce 
uncontrolled cell death (necrosis) (Degterev and Yuan 2008). After the initial screening of 
anti-proliferative activity, the extracts — E2 and E4 — that showed an IC50 lower than 200 
µg ml-1 were selected for the next studies. 
The reduction of the number of viable cells could be due to an increase of cell death 
and/or decreased cell proliferation. In our study, the suggestive induction of cell death 
(apoptosis) by extracts was first noticed through the observation of morphological alterations 
such as cell shrinkage, membrane blebbing, and rounded and detached cells, in a phase 
	   CHAPTER II 
 
	  
	   51 
contrast microscope, and then confirmed by chromatin condensation using DAPI staining. 
The decrease of long-term cell proliferation is considered a cytostatic effect and may be 
evaluated by clonogenic cell survival assay. In summary, this assay measures the ability of 
a clonogenic cell to proliferate and form a viable colony after being exposed to a particular 
chemical agent for a certain amount of time, and then returned to fresh medium and left to 
proliferate (Rafehi et al. 2011).  
Our data suggest that the in vitro anticancer effect of extract E4 in HepG2 and HCT116 
cells could be due to both an increase of cell death and a decrease of long-term cell 
proliferation. In A375 cells, extract E4 decreased the number of viable cells, without an 
induction of cell death and presenting a slight decrease of colony formation. In this case, 
extract E4 seems to only inhibit cell proliferation at short-term; however at long-term the 
alterations induced by the extract seems to be reverted or repaired in A375 malignant 
melanoma cells. This lack of long-term inhibition may be explainable in view of what has 
been observed in other studies, which have shown that malignant melanoma is resistant to 
chemotherapy based on DNA damage induction, besides the normal function of p53 
(Barckhausen et al. 2014). Such chemotherapy-resistance of melanoma cells seems to be 
related to the upregulation of some DNA repair genes (Li and Melton 2011).   
Although until now no compounds have been isolated from the marine-derived strain of 
N. siamensis KUFA 0017, in a study by Buttachon et al. (2012), several compounds were 
isolated from a terrestrial strain N. siamensis KUFC 6349, namely, sartorymensin, 
tryptoquivaline, tryptoquivalines F, H, L and O, fiscalins A and C, epi-fiscalin A and C, epi-
neofiscalin A, neofiscalin A and 4-dihydroxy-3- methylacetophenone. In the same study, 
selected compounds were screened for in vitro cytotoxic activity in a panel of cancer cell 
lines; results showed that sartorymensin, tryptoquivaline O and F showed an IC50 range 
between 72 and 91 µM in MCF-7 and U373 cells (Buttachon et al. 2012). Additionally, 
Sondgam et al. (2014) showed that tryptoquivaline L, epi-fiscalin A and C, isolated from 
Xylaria humosa, have cytotoxic effects in MCF-7 cells with an IC50 range between 21 and 
33.6 µg ml-1 (Sodngam et al. 2014). If the nature of the compounds of the marine-derived 
strain is similar to the mentioned terrestrial counterpart, it is possible to hypothesize that 
some of the referred compounds may be responsible for the anticancer activity of extract E4. 
However, further studies should be addressed. 
The in vitro anticancer activity of extract E2 in HepG2 and HCT116 cells was mainly due 
to the induction of cell death and decrease of long-term proliferation of survival cells. In 
HepG2 cells, the induction of cell death could be related with the ability of extract E2 to 
induce DNA damage. This characteristic is common to several chemotherapeutic drugs, 
which reveal an anticancer activity mainly due to their ability to induce DNA damages (Fu et 
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al. 2012). If such DNA damages are not properly repaired, their accumulation ultimately 
ensues in cell death (Roos and Kaina 2013). In agreement with our data, also other marine 
sponge-derived compounds such as scalaradial, cacospongionolide and 10-
acetylirciformonin B increased DNA damage, which resulted in the induction of cell death by 
apoptosis in several cancer cell lines (De Stefano et al. 2012; Su et al. 2012). Gomes et al. 
(2014) have been isolated some compounds from the marine-derived fungus Neosartorya 
paulistensis KUFC 7897, namely, sartorypyrone C, tryptoquivalines H, L, F, 4(3H)-
quinazolinone and 3′-(4-oxoquinazolin-3-yl) spiro [1H-indole-3,5′]-2,2′-dione (Gomes et al. 
2014). As referred before tryptoquivaline L showed a cytotoxic activity against MCF-7 cells 
(Sodngam et al. 2014). It is thus possible to suggest that tryptoquivaline L and some others 
compounds may be in some measure responsible for the anticancer activity of extract E2. 
Several compounds isolated from marine fungi have been reported as cell death 
inducers. Physcion, an anthraquinone isolated from the marine-derived 
fungus Microsporum sp., was found to exhibit a cytotoxic effect in HeLa cells by inducing 
apoptosis (Wijesekara et al. 2014). Fumigaclavine C, isolated from marine-derived fungus 
Aspergillus fumigatus, induced cell cycle arrest and apoptosis in MCF-7 cells. This 
compound seems to act by down-regulation of the NF-kB cell survival pathway (Li et al. 
2013). Gliotoxin, isolated from several Aspergillus, Penicillium and Gliocladium species, 
inhibited cell proliferation and induced apoptosis via the mitochondrial pathway in HeLa and 
SW1353 cells (Nguyen et al. 2013). Bostrycin, a compound isolated from marine fungi in the 
South China Sea, inhibited cell proliferation and induced apoptosis in prostate, gastric and 
lung cancer cells (Sawadogo et al. 2013). 
In A375 cells, extract E2 decreased long-term cell proliferation (diminished colony 
formation) without effects on induction of cell death; at the tested conditions. Decrease of 
clonogenic survival may be related with induction of senescence and mitotic castatrophe 
(Roninson et al. 2001; Luo et al. 2013).  
Doxorubicin is an anticancer drug commonly used in the chemotherapeutic treatment of 
several different types of cancers. Its cytotoxic effect has been related with free radical 
formation, inhibition of DNA topoisomerase II and nucleotide intercalation, resulting in cell 
cycle arrest and apoptosis (Thorn et al. 2011). Some authors refer an activation of the tumor 
suppressor gene p53 after an exposure to Dox, and consequently p53 acts as a 
transcription factor of target genes, such as PUMA and BAX, inducing cell cycle arrest and 
apoptosis (Wang et al. 2013). In our study, the in vitro anticancer activity of Dox, used as a 
positive control, seems to be related with a decrease in long-term cell proliferation and 
induction of cell death. However, in accordance with other studies, in HCT116 cells Dox 
reduces the number of viable cells without an induction of apoptosis (Lüpertz et al. 2010). 
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Induction of cell death by Dox seems to depend on factors such as dose, exposure time and 
cell line used. Even so, facing our aims, Dox’s exact mechanisms do not jeopardize it as 
control. 
Genetic characteristics of cells, namely p53 status, influence its susceptibility to 
chemotherapy. p53 protein act as tumor suppressor, coordinating different activities such as 
cell death , cell cycle arrest, senescence, differentiation and DNA repair by interaction with 
different proteins (Oren 2003; Borges et al. 2007). Herein, the IC50 values for Dox were 
higher in HT29 and U251 cells (both p53 mutant) when compared with the other tested cell 
lines, demonstrating that these cells possess a more Dox resistant phenotype. Some studies 
have associated, in part, the Dox resistant phenotype to p53 status (Fojo and Bates 2003; 
Wang et al. 2013). Moreover, extracts E2 and E4 showed significant in vitro anticancer 
effects in three cell lines that are p53 wild-type. In fact, none of the tested extracts showed 
effects in p53 mutant cells, which suggests that the in vitro anticancer activity of the extracts 
could be p53 dependent. Both extracts also presented different ability to inhibit cell 
proliferation and induce cell death in the same cell line, strongly supporting that each extract 
acts through different molecular targets. Even so, the extracts’ ability to decrease long-term 
cell proliferation and induce cell death is dependent of cell type, and thus it is plausible that 
other genetic features beyond the p53 status may influence these effects. Following this 
initial screening, more studies should be carried out to clarify the molecular mechanisms 
involved on the in vitro anticancer activity of extracts E2 and E4. 
In summary, our study shows for the first time that crude ethyl acetate extracts obtained 
from marine-derived fungi N. paulistensis and N. siamensis have in vitro anticancer 
activities, by causing a decrease in cell proliferation and/or induction of cell death in 
hepatocellular carcinoma, colon carcinoma and melanoma cells. The inherent molecular 
targets and related signal transduction pathways should be researched in the future. 
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3.1. Manuscript 
 
Abstract 
 
Aim of the study: To evaluate the anticancer activity of nine compounds 
isolated from the extract of marine sea fan fungus Neosartorya siamensis 
(KUFA 0017), obtained from the Similan Islands of Thailand. 
Material and methods: Nine compounds isolated from the marine sea fan 
derived fungus Neosartorya siamensis (KUFA 0017), namely 2,4-dihydroxy-3-
methylacetophenon (C1), nortryptoquivaline (C2), chevalone C (C3), 
tryptoquivaline H (C4), fiscalin A (C5), epi-fiscalin C (C6), epi-neofiscalin A 
(C7), epi-fiscalin A (C8) and tryptoquivaline F (C9) were tested for anti-
proliferative activity by MTT assay, DNA damage induction by comet assay 
and induction of cell death by nuclear condensation assay on colon HCT116, 
liver HepG2 and melanoma A375 cancer cell lines.  
Results: Compounds C2, C3, C5, C6, C7 and C8 presented IC50 values 
ranging from 24 to 153 µM in the selected cell lines. Cell death was induced in 
HCT116 by compounds C2, C3 and C5. In HepG2, compounds C2, C5, C7 
and C8 were able to induce significant cell death. This induction of cell death 
is possibly not related to genotoxicity since none of the compounds induced 
significant DNA damage.  
Conclusion: Results suggest that compounds C2, C3, C5, C6, C7 and C8 
present anti-proliferative activity and induce cell death, showing potential as 
future chemotherapeutic agents. Data justifies that further studies on 
mechanisms of action should be ensued.  
	  
Keywords: Anticancer activity; marine-derived fungi compounds; cancer cell 
lines; Neosartorya siamensis; cell death induction; cytotoxicity.  
Abbreviations: Doxorubicin (Dox); Dimethyl sulphoxide (DMSO); 2,4-
Dihydroxy-3-methylacetophenon (C1); Nortryptoquivaline (C2); Chevalone C 
(C3); Tryptoquivaline H (C4); Fiscalin A (C5); Epi-fiscalin C (C6); Epi-
neofiscalin A (C7); Epi-fiscalin A (C8); Tryptoquivaline F (C9). 
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1. Introduction 
 
According to the latest global census (GLOBOCAN 2012) there was an estimate of 
14.1 million new cases of cancer in 2012 and 32.6 million people living with cancer, 
resulting in 8.2 million deaths. Colorectal and liver cancers are amongst the top ranking 
cancers in terms of diagnostic frequency, and with the highest mortality rates (Ferlay et 
al., 2013). Malignant melanoma, however, has shown a significant increase in the last 
decades, mostly in developed countries with populations with fairer skin (Erdmann et al., 
2013). The increase of life expectancy, growth of population, exposure to hazardous 
environmental factors and engagement in risk behaviours, have given cancer the 
opportunity to become a global leading cause of death, and the number of cases is 
steadily increasing (Jemal et al., 2011). The development of cancer and the behavior of 
cancerous cells is characterized by several hallmarks: the induction of angiogenesis, the 
evading of growth suppressors, the sustaining of proliferative signaling, the enabling of 
replicative immortality, the activation of invasion and metastasis, and the resistance to cell 
death (Hanahan and Weinberg, 2011). Most desired for therapy are drugs that overcome 
the challenges inherent to cancer hallmarks and that exploit the vulnerabilities of cancer 
cells.   
 
The search for anticancer drugs within natural sources has mobilized several research 
fields. New chemotherapeutic drugs are needed, in particular to attenuate the many 
harmful side effects observed with current common-use chemotherapeutics (Aluise et al., 
2010; Nematbakhsh et al., 2012; Saad et al., 2014). While plants and terrestrial 
microorganisms have been in the limelight of natural product search for several decades, 
the marine environment is one of the current hotspots for the bio-prospection of new 
bioactive molecules (Montaser and Luesch, 2011). The vastness of the ocean hosts an 
impressive array of biodiversity, which is still largely unexplored. Nonetheless, several 
compounds of marine origin have been approved for clinical use, and several more are 
currently under clinical trials (Newman and Cragg, 2014; Schmidtko et al., 2010). 
Microorganisms have been some of the most prolific sources of bioactive compounds 
among marine organisms, much to the like of their terrestrial counterparts (Xiong et al., 
2013). Marine fungi are now recognized as a prolific source of bioactive secondary 
metabolites, many of which are novel compounds presenting distinctive structural 
features. Metabolites of marine fungal origin have been described as having anticancer, 
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anti-inflammatory, antimicrobial and antiviral activity, amongst others (Elsebai et al., 2011; 
Lee et al., 2013; Li et al., 2013; Shushni et al., 2011). 
 
Neosartorya siamensis (KUFA 0017) is a marine fungus associated to the Rumphella 
sp. sea fan. The Neosartorya belongs to the phylum Ascomycota, and species of that 
genus have been described to occur in the soil, air, organic materials, food, human 
habitations and also the marine environment (Yaguchi et al., 2010). In recent years, 
efforts have been made to isolate secondary metabolites from marine-derived 
Neosartorya sp., which have yielded several compounds with potential bioactivity 
(Eamvijarn et al., 2013; Gomes et al., 2014). In this quest, a recent study brought to light 
that the crude ethyl extract of Neosartorya siamensis (KUFA 0017) has anti-proliferative 
activity as well as cell death induction ability in three cancer cell lines (A375, HepG2 and 
HCT116) (Prata-Sena et al., 2014) having these results motivated this current study.  
 
The aim herein was to assess the anticancer activity of nine compounds isolated from 
the marine sea fan derived fungus Neosartorya siamensis (KUFA 0017) — 2,4-dihydroxy-
3-methylacetophenone (C1), four pyrazinoquinazoline derivatives, fiscalin A (C5), epi-
fiscalin C (C6), epi-neofiscalin A (C7) and epi-fiscalin A (C8), three quinazoline derivatives, 
nortryptoquivaline (C2), tryptoquivaline H (C4) and tryptoquivaline F (C9), and the 
meroterpenoid chevalone C (C3) — on three selected human cancer cell lines, malignant 
melanoma (A375), hepatocellular carcinoma (HepG2) and colon carcinoma (HCT116), in 
accordance to results obtained in our previous study (Prata-Sena et al., 2014). 
 
2. Experimental Section  
 
2.1. Reagents 
 
Roswell Park Memorial Institute medium (RPMI-1640), Minimum Essential Medium 
Eagle medium (MEM), Dulbecco’s modified Eagle’s medium (DMEM), sodium pyruvate, 
sodium bicarbonate, N-(2-hydroxyethyl)piperazine-N’-(2-ethanesulfonic acid) (HEPES), 
trypsin solution, 4,6-diamidino-2-phenylindole (DAPI), penicillin/streptomycin, doxorubicin, 
and 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) were purchased 
from Sigma-Aldrich (St. Louis, MO, USA). Fetal bovine serum (FBS) was purchased from 
Biochrom KG (Berlin, Germany). Dimethyl sulfoxide (DMSO) was purchased from 
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AMRESCO LLC (Solon, SO, USA). All other reagents and chemicals used were of 
analytical grade.  
 
2.2. Fungal material 
Neosartorya siamensis (KUFA 0017) was isolated from sea fan (Rumphella sp.), 
collected from the coral reef at Similan Island, PhangNga province, Southern Thailand, by 
scuba diving at 10 m depth, in April 2010. Briefly, the sea fan tissue was cut into a piece 
of 0.5 cm x 0.5 cm, placed on the malt extract agar (MEA) with 70% sea water and 
incubated for 28ºC for 7 days. The fungus was identified by Professor Tida Dethoup, by 
morphological features, including the characteristic of ascospores and colonies. The 
identification was supported by sequence analysis of the β-tubulin gene, described in the 
previous reportas in Glass and Donaldson (1995), and the pure cultures were deposited 
as KUFA 0017 at Kasetsart University Fungal Collection, Department of Plant Pathology, 
Faculty of Agriculture, Kasetsart University, Bangkok, Thailand. 
  
2.3. Extraction of metabolites 
The isolation of compounds from the marine-derived fungus Neosartorya siamensis 
(KUFA 0017) was performed by Professor Anake Kijjoa and collaborators from ICBAS and 
CIIMAR. The extraction of metabolites was made according to Buttachon et al. (2012). 
 
2.4. Cell culture  
The A375 cell line (human malignant melanoma) was acquired from the European 
Collection of Cell Cultures (ECACC). HCT116 cells (human colon carcinoma) were kindly 
provided by Professor Carmen Jerónimo from IPO, Porto. The HepG2 cells (human 
hepatocellular carcinoma) were kindly provided by Professor Rosário Martins from 
CIIMAR, Porto.  Cells were maintained as monolayer cultures, respectively, in MEM for 
HepG2 cells, DMEM for HT29 cells, and RPMI for HCT116 cells. All mediums were 
supplemented with 10% FBS, 10 mM HEPES, 0.1 mM sodium pyruvate and 1% antibiotic 
solution (100 µg/ml streptomycin and 100 U/ml penicillin). Cells were maintained in a 
humidified incubator at 37ºC and 5% CO2 atmosphere. The medium was changed every 
two days, and when reaching confluence, cells were trypsinised and sub-cultured.  
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Stock solutions of the compounds and doxorubicin were prepared in DMSO and stored 
at -20ºC. At the beginning of all experiments, compounds and doxorubicin were dissolved 
in fresh culture medium, with a final concentration of DMSO no higher than 0.5%. 
Negative controls were subjected only to culture medium with a maximum of 0.5% of 
DMSO (v/v), to assess the effect of the solvent.  
 
2.5. MTT colorimetric assay 
 
The MTT colorimetric assay was performed to assess the cell viability/proliferation 
effects of the tested compounds in HepG2, HCT116 and HT29 cell lines. In short, cells 
were plated in 96-multiwell culture plates at a density of 1 x 104 cells/well. After plating, 
cells were left to adhere for 24 h in a humidified incubator at 37ºC and 5% CO2. Cells 
were incubated with fresh RPMI medium prepared with a ranging concentration of 
compounds (1, 10, 50, 100 and 200 µM) and doxorubicin (0.001, 0.01, 0.1, 1 and 10 µM) 
as a positive control. Negative controls contained only medium with 0.5% DMSO. All 
solutions when incubated with cells contained a maximum of 0.5% DMSO. For the initial 
control (t = 0), 0.5 mg/ml of MTT solution was added, left to incubate at 37ºC and 5% CO2 
for 2 hours and then the medium and MTT solution were removed. The cells treated with 
compounds and controls were then left to incubate at 37ºC and 5% CO2 for the remaining 
46 h of treatment. Subsequently, 0.5 mg/ml of MTT solution was added to all treatment 
conditions and incubated for 2 h at 37ºC. The formazan crystals formed during incubation 
were dissolved by adding 150 µl of DMSO:ethanol solution (1:1) (v/v), which was left to 
incubate in a plate shaker for 10 min. Absorbance (A) was read at 570 nm in a microplate 
reader (Multiskan EX, Labsystems, USA). The value of absorbance reflects the amount of 
formazan crystals produced by viable mitochondria in cells by the reduction of MTT, and is 
frequently used as an indicator of cell viability and cell proliferation (Vega-Avila & Pugsley, 
2011). The half maximal inhibition concentration values (IC50) of the compounds and 
doxorubicin were calculated by analysing dose-response data with GraphPad Prism v5.0 
software (GraphPad Software, La Jolla, CA, USA). 
 
2.6. Alkaline single cell electrophoresis assay (Comet Assay) 
 
The genotoxic effects of the tested compounds were assessed by single cell 
electrophoresis assay, or comet assay. Cells were plated at a density of 0.1 x 106 cells/ml 
on 24-multiwell culture plates and left to adhere for 24 hours. Thereupon, cells were 
exposed to the respective IC50 concentrations (Table 1) of compounds and doxorubicin, 
and left to incubate for 48 h. After the incubation, an alkaline version of comet assay was 
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used to assess DNA damage in the form of alkali-labile sites and strand breaks (Collins et 
al., 2008; Olive and Banáth, 2006). After the conclusion of the treatment, cells were 
maintained on ice to avoid DNA repair. In summary, 5 x 104 cells were collected per 
sample and were resuspended with 0.5% (w/v) low melting agarose. Subsequently, cells 
were set on microscope slides coated with 1% (w/v) normal melting agarose and left to 
solidify at 4ºC for 10 min. Slides were then incubated for 1 h at 4ºC in lysis solution (2.5 M 
NaCl, 100 mM Na2EDTA, 10 mM Tris, pH 10) with the addition of 1% (v/v) Triton X-100. In 
order to allow the DNA to unwind, slides were placed in a horizontal electrophoresis 
chamber and incubated in an alkaline electrophoresis buffer (300 mM NaOH, 1 mM 
Na2EDTA, pH 13) for 40 min at 4ºC. Afterwards, an electrophoresis at 20 V was run for 20 
min at 4ºC. Slides were washed twice in distilled water, fixed with 100% ethanol, left to air 
dry at room temperature and incubated with DAPI (1 µg/ml) for 10 min, protected from 
light. Samples were then observed by fluorescence microscopy (Olympus IX71), with a 
minimum of 100 randomly selected cells being observed per sample, and resulting images 
were analysed using the CometScore® software (CometScore, TriTek Corp.), to calculate 
the parameter “percentage of tail intensity”.  
 
2.7. Nuclear condensation assay 
 
The effect of the compounds on the induction of cell death was analysed by a nuclear 
condensation assay, which is one of the features of apoptosis (Toné et al., 2007). Briefly, 
cells were plated at a density of 1 x 106 cells/ml in 24-multiwell culture plates and left to 
adhere for 24 h. Thereafter, cells were incubated with two or three selected 
concentrations, ranging from 10 to 150 µM, according to the cell line and respective IC50 
value (Table 1) for each compound and doxorubicin for 48 h. After the incubation, the 
cells were washed and trypsinised, assuring that both adherent and detached cells were 
collected, then centrifuged several times and fixed with 4% (w/v) paraformaldehyde in 
PBS for 15 min at 37ºC. At the end of protocol, samples were stored at 4ºC in PBS until 
further use. Prior to use, cells were mounted on poly-L-Lysine-covered microscope slides 
by cytocentrifugation (Cell Spin Cytospin) and left to air dry at room temperature. Once 
dried, samples were circled with hydrophobic barrier pen and the slides were washed 
thrice for 5 min. To stain the nuclei, samples were incubated with DAPI solution (1µg/ml) 
for 10 min, protected from light. Condensed nuclei were observed by fluorescence 
microscopy (Olympus IX71). At least 3 different fields were observed, resulting in a 
minimum of 300 cells scored per sample. Results were analysed by applying the following 
equation: % of cell death = number of cells with condensed nuclei / total number of cells. 
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2.8. Statistical analysis 
 
Analyses were made with the GraphPad Prism v6.0 software (GraphPad Software, La 
Jolla, CA, USA). Results were expressed as mean and standard deviation (SD) from at 
least 3 independent experiments. Outlier detection was performed using a ROUT test 
(Q=10%). Data were analysed for normal distribution and homogeneity of variances using 
the Kolmogorov-Smirnov test and Bartlett’s test, respectively. One-way ANOVA was 
performed to assess significant differences (p ≤ 0.05) between treatment conditions and 
the negative control, followed by post hoc multiple comparisons using the Newman-Keuls 
test. A Student’s t-test was used to verify significant differences when appropriate.  
3. Results 
 
3.1. Evaluation of cell proliferation by MTT colorimetric assay 
 
The assessment of the effect on cell viability and proliferation of the nine tested 
marine-derived compounds (2,4-dihydroxy-3-methylacetophenon (C1), nortryptoquivaline 
(C2), chevalone C (C3), tryptoquivaline H (C4), fiscalin A (C5), epi-fiscalin C (C6), epi-
neofiscalin A (C7), epi-fiscalin A (C8) and tryptoquivaline F (C9)) was performed by an 
MTT colorimetric assay using three cancer cell lines, malignant melanoma (A375), 
hepatocellular carcinoma (HepG2) and colon carcinoma (HCT116). Each cell line was 
incubated with a varying concentration of compounds (1, 10, 50, 100 and 200 µM). 
Doxorubicin at the concentrations of 0.001, 0.01, 0.1, 1 and 10 µM was used as a positive 
control, whereas negative controls correspond to the cells incubated only with medium 
with 0.5% DMSO. The half maximal inhibitory concentration values (IC50) values for each 
cell line were calculated by the analysis of dose-response curves. The IC50 values and 
respective 95% confidence intervals (CI) are summarized in Table 1.  
Nortryptoquivaline (C2) was broadly effective in decreasing the viability in HCT116, 
HepG2 and A375, with IC50 values of 114 µM, 58 µM and 108 µM, respectively. Epi-
fiscalin C (C6) also presented a broad effect across all cell lines, however, showing a 
greater inhibition of viability, with IC50 values of 86 µM for HCT116, 24 µM for HepG2 and 
75 µM for A375 cell line. Chevalone C (C3) exhibited a significant decrease of cell viability 
in melanoma (A375) and colon carcinoma (HCT116) cell lines, with IC50 values of 98 µM 
and 153 µM, respectively. Fiscalin A (C5) also exhibited a considerable inhibition of cell 
viability in two cancer cell lines, with IC50 values of 123 µM for HCT116 and of 53 µM for 
HepG2 cells. Epi-neofiscalin A (C7) and epi-fiscalin A (C8) only presented a significant 
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decrease of cell viability in liver hepatocellular carcinoma cells (HepG2), with respective 
IC50 values of 76 µM and 115 µM. Tryptoquivaline H (C4) and tryptoquivaline F (C9) were 
overall ineffective in two cell lines, having the first only been narrowly inhibitory in HCT116 
and the latter in HepG2. 2,4-Dihydroxy-3-methylacetophenon (C1) failed to cause significant 
alterations in cell viability in any of the cell lines, which prevented the calculation of an 
IC50. Only the compounds presenting an IC50 of approximately equal of lower than 150 µM 
were selected for the following assays; this criterion is sustained by the need of assuring 
concentrations that are viable in further in vivo studies. The positive control, doxorubicin 
presented and IC50 of 0.13 µM for HCT116, 0.11 µM for HepG2 and 0.08 µM for A375.  
The effect of the compounds on cell proliferation was assessed by an MTT assay, 
where the total of viable cells at the beginning of the experiment (t = 0 h) was subtracted 
from the total of viable cells at the end of the experiment (t = 48 h). Hence, results were 
expressed in percentage, considering 100% proliferation that equal to the negative control 
(0.5% DMSO) at 48 h, and 0% proliferation that equal to the negative control at 0 h. 
Compound treatments with proliferation percentages ranging from 0% to under 100% are 
considered as presenting an anti-proliferative effect while negative percentages imply 
direct cytotoxic effects of compounds. 
In HCT116 cell line, the compounds C2, C3, and C5 slightly decrease cell proliferation 
when tested at 50 µM, showing cell proliferation inhibitions of 19%, 16% and 22%, 
respectively. Compound C6 exhibited a significant inhibition of cell proliferation around 
58% (Table 2). At 200 µM, the compounds C2, C3, and C5 showed a direct cytotoxic 
effect on HCT116 cells (Figure 1A). 
In HepG2 cell line, compounds C2, C5, and C6 presented a strong cell proliferation 
inhibition of 83, 77 and 99%, respectively, at 50 µM. Compounds C7 and C8 also 
significantly inhibit cell proliferation, but with more moderate activity, obtaining 59 and 
50% of inhibition at 50 µM (Table 2). The compound C6 at 1 µM already showed a 
significant decrease of cell proliferation as observed in Figure 1B. Compounds, C2, C5 
and C6 at 100 and 200 µM showed direct cytotoxic effect (observed by negative values) 
(Figure 1B).  
In the A375 melanoma cell line, compounds C2, C3 and C6 caused a significant 
inhibition of cell proliferation at 50 µM, by 27, 39 and 53%, respectively (Table 2). Figure 
1C shows that the three compounds, at 200 µM, showed direct cytotoxic effects. Though 
the compound C6 showed a very promising anti-proliferative effect, due to exhaustion of 
the isolated stock it was impossible to make with further studies within this study scope. 
Doxorubicin, the positive control, caused a decrease in cell proliferation in a dose-
dependent manner in all tested cell lines (data not shown). Doxorubicin at 0.1 µM 
significantly inhibited proliferation of HCT116, HepG2 and A375 cells, by 60, 82 and 87%, 
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respectively (Table 2). The anti-proliferative effect of the compounds was also observed 
by phase contrast microscopy, where alterations in cell morphology, density and cell 
detachment were detected, as shown in Figure 2.  
 
Table 1 – Half maximal inhibitory concentrations (IC50), in µM, and respective 95% confidence 
intervals of compounds C1 to C9 and doxorubicin (positive control) in three cell lines as determined 
by the MTT assay. 
 
 
The “-“ means “not determined”. 
 
 
Table 2 – Percentage of cell proliferation inhibition, relative to the negative control, of the 
compounds, at 50 µM, and doxorubicin, at 0.1 µM, in HCT116, HepG2 and A375 cells. 
 
 
 
 
 
Compound (50 µM) 
 
% of cell proliferation inhibition (relative to control) 
 
HCT116 HepG2 A375 
C2 19 83 27 
C3 16 - 39 
C5 22 77 - 
C6 58 99 53 
C7 - 59 - 
C8 - 50 - 
Doxorubicin (0.1 µM) 60 82 87 
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Figure 1 – Effect of compounds on cell proliferation in HCT116 (A), HepG2 (B) and A375 (C) cells 
after 48 h, evaluated by MTT assay. Results are expressed as mean + SD of at least three 
independent experiments, in duplicate. Significant differences (*p ≤ 0.05; ** p ≤ 0.01, *** p ≤ 0.001 
and **** p ≤ 0.0001) when compared with control cells were determined by one-way ANOVA, 
followed by a Newman-Keuls Multiple comparison test. 
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Figure 2 - Phase contrast morphology of HCT116 cells treated with (A) 0.5% DMSO (negative 
control); (B) doxorubicin at 0.1 µM; (C) compound C2 at 150 µM and HepG2 cells treated with (D) 
0.5% DMSO (negative control); (E) doxorubicin at 0.1 µM; (F) compound C2 at 150 µM. Rounded 
and detached cells (arrows). 
 
3.2. Evaluation of genotoxic effects by single cell electrophoresis assay 
 
The analysis of DNA damage of alkali-labile sites and strand breaks was assessed by 
comet assay regarding a 48 h exposure to the IC50 value of the compounds presenting an 
IC50 ≤ 150 µM in HCT116, HepG2 and A375 cancer cell lines. The analysis of the results 
revealed that none of the compounds causes significant damage to the DNA detectable 
by comet assay (data not shown).  
 
3.3. Evaluation of cell death induction by nuclear chromatin condensation assay 
 
Considering that the observed anti-proliferative effect induced by the compounds may 
be due to the induction of cell death, a nuclear chromatin condensation assay was 
performed after a 48 h exposure of the three cell lines (HCT116, HepG2 and A375) to the 
compounds that exhibited an IC50 ≤ 150 µM (Figure 3).  
The concentrations of compounds to which the cell lines were exposed in the nuclear 
condensation assay and the comet assay were based on the IC50 values obtained from 
the MTT assay, thus in general three concentrations were used, one concentration 
approximate to the IC50 value, one above and one below. HCT116 and A375 were both 
exposed to the compounds C2 and C3 at a range of concentrations of 50, 100 and 150 
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µM, while HCT116 was also exposed to the compound C5 at 50 and 150 µM. HepG2 was 
exposed to the compounds C5 and C7 at a range of concentrations of 10, 50 and 100 µM, 
as well as to C2 and C8 at 50, 100 and 150 µM. All experiments had as a positive control 
0.1 µM of doxorubicin and as a negative control medium with 0.5% of DMSO. 
In A375 cells, only doxorubicin exhibited a significant (p < 0.001) increase of cells with 
condensed nuclei by 21%. The compounds tested (C2 and C3) evidenced no statistically 
significant variations in the amount of cells with condensed nuclei — this at the tested 
concentrations and when compared with the negative control; accordingly, neither was it 
possible to observe a clear dose-response effect (data not shown).  
HCT116 cells were sensitive to the induction of nuclear condensation in a dose-
response manner by all the three compounds (Figure 3A). Compounds C2 and C5 were 
the most potent compounds regarding this cell line, and at a concentration of 150 µM 
demonstrated an increase of 11% and 10%, respectively, in relation to the negative 
control. Compound C3 exhibited an increase of 6% and 8% at 100 µM and 150 µM, 
respectively. In HCT116 cells, doxorubicin did not present a clear significant difference in 
relation to the negative control (p = 0.0549). However, the proximity to p ≤ 0.05 may 
indicate marginal significance, and thus considering, doxorubicin revealed a 7% increase 
in relation to control. 
All the tested compounds induced nuclear condensation in hepatocellular carcinoma 
cell line at one or more concentrations (Figure 3B). Compound C7 exhibited a significant 
effect in all three of the tested concentrations, with an increase of 4%, 6% and 8%, 
respectively, at 10 µM, 50 µM and 100 µM. Compound C2 displayed a significant increase 
of cells with condensed nuclei at two concentrations, presenting 5% and 6% at 100 µM 
and 150 µM, respectively. Compound C5 showed an increase of 5% of cells with 
condensed nuclei at 100 µM. Meanwhile, compound C8 presented an 8% increase in 
relation to control at 150 µM. Doxorubicin induced an increase of 12% in relation to the 
negative control.  
HepG2 cells were clearly the most sensitive to the compounds’ activity, being affected 
by all four tested compounds, and in one case having had induction of chromatin 
condensation in a concentration as low as 10 µM. 
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Figure 3 – Effect of compounds C2, C3, C5, C7 and C8, accordingly, on the induction of nuclear 
chromatin condensation in (A) HCT116 and (B) HepG2 cells, as assessed by a nuclear 
condensation assay. Percentages refer to the increment of cells with condensed nuclei in relation 
to the negative control. Results are the mean + SD of at least three independent experiments. 
Significant differences (*p ≤ 0.05; ** p ≤ 0.01, *** p ≤ 0.001 and **** p ≤ 0.0001) when compared 
with the negative control were determined by a One-way ANOVA followed by a Newman-Keuls 
Multiple comparison test. Additionally, an unpaired Student’s t-test was selectively used to assess 
significant differences in relation to the negative control in HepG2 for C2 (100 and 150 µM), C5 
(100 µM), C7 (10 µM) and doxorubicin (0.1 µM).  
 
4. Discussion 
To our knowledge, this is the first time that compounds are isolated from the marine 
sea fan derived fungus Neosartorya siamensis (KUFA 0017). Although these compounds 
are not novel isolates, it is the first time that their anti-proliferative activity is described in 
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HepG2 hepatocellular carcinoma, HCT116 colon carcinoma and A375 malignant 
melanoma cell line, accompanied by mechanistic assessment of genotoxicity (detection of 
DNA damage, such as strand breaks and alkali-labile sites) and induction of cell death. 
In our study, effects on cell viability/proliferation were assessed by an MTT assay and 
all compounds tested, in exception to compounds C1, C4 and C9 significantly decreased 
cell viability and proliferation in one or more of the cell lines tested. The anti-proliferative 
effect of the compounds could be due to induction of cell death and/or cell cycle arrest. 
Morphological features of cell death by apoptosis, such as membrane blebbing, cell 
shrinkage, rounding and detachment, were visible by phase contrast microscopy after an 
incubation of 48 h with compounds, and these features are corroborated by the 
observation of nuclear chromatin condensation. The nuclear condensation assay is used 
to detect nuclear chromatin condensation, which in turn is one of the key features of 
apoptosis (Kroemer et al., 2009). In normal conditions, chromatin is heterogenous and 
spaciously packaged in nuclei, becoming more condensed in the event of mitosis, 
however, upon the unraveling of apoptosis, nuclear chromatin becomes exceptionally 
condensed and fragmented, and alongside nuclear proteins, ends up forming what is 
commonly known as apoptotic bodies (Toné et al., 2007). Thus, the increase of cells with 
condensed nuclei suggests an increase of cell death, most probably by apoptosis.  
HepG2 hepatocellular carcinoma cell line was by far the most sensitive line to the 
panel of compounds. In fact, almost all the compounds, except C1 and C4, proved to 
have an anti-proliferative effect in a dose-dependent manner in this cell line. 
Notwithstanding, the IC50 values observed regarding HepG2 were also the most 
promising, as the values were inferior to 100 µM in four cases (C2, C5, C6 and C7), 
reaching the lowest concentration of 24 µM for compound C6. Inclusively, the compound 
C6 was able to inhibit cell proliferation at the smallest tested concentration (1 µM) with an 
inhibition of > 35%, which increased consistently at higher concentrations. This is 
particularly interesting since an anti-proliferative activity at such low doses may possibly 
imply a lesser amount of side effects. Compound C3 yielded an IC50 value above the pre-
determined threshold (≤ 150 µM) and was thus not considered for further assays. The 2,3-
dihydrosorbicillin compound, obtained from the terrestrial endophytic fungi Penicillium sp. 
P-1, exhibited an anti-proliferative activity on HepG2 cells, with an IC50 of 44 µM. In 
addition, resveratrodehyde C, obtained from the marine mangrove endophytic fungi 
Alternaria sp. R6, obtained an IC50 of 41.86 µM in HepG2 cell line. Both these fungal 
compounds show a degree of cytotoxic activity similar to our own compounds against this 
hepatocellular carcinoma cell line. Furthermore, our results indicated that the compounds 
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C2, C5, C7 and C8 acted also by inducing cell death, since all compounds caused a 
significant increase of cells with condensed nuclei, to a varying extent and mostly in 
accordance with increasing dose. However, the induction of cell death in HepG2 was to 
some extent lower than that in HCT116. This may imply that in the liver cancer cell line the 
compounds’ action may be also strictly related to inhibition of proliferative mechanisms. 
In HCT116 colon carcinoma cell line, the effect of the compounds on cell 
viability/proliferation was in general weaker than that observed in HepG2. The compounds 
showing a suitable effect, C2, C3, C5 and C6, presented IC50 values ranging from 86 to 
153 µM. Once more, it can be observed that compounds C5 and C6, both belonging to 
the fiscalin family, also play an interesting role in HCT116 cells, alongside compound C2, 
which is also responsible for a generalist activity by acting in the three cell lines tested. 
These three compounds obtained the highest cell proliferation inhibition percentages 
(Figure 1). The colon carcinoma cell line seems to be positively influenced by compounds 
C2, C3 and C5 in terms of an increment of cells with condensed nuclei, ultimately 
indicating an increase of cell death in a concentration-dependent manner (Figure 3). This 
is consistent to the results obtained from the proliferative screening, and interestingly this 
cell line seems to be slightly more affected by the induction of cell death than the other 
tested cell lines. This may suggest that the compounds are successfully interfering in cell 
death mechanisms, most probably by promoting a pro-apoptotic response. Once more, 
there is no evidence that the compounds have the ability to induce DNA damage, at least 
considering damage detectable by the alkaline version of the comet assay, in the form of 
strand breaks or alkali-labile sites. 
A375 melanoma cell line was overall the most selective in terms of compound 
sensitivity. Only three compounds, C2, C3 and C6, resulted in fitting IC50 values (≤ 150 
µM) and with values similar to those observed in HCT116 cells. The remaining 
compounds C4, C7 and C8 did not reach the pre-established threshold for the IC50. In 
A375 cells, the compounds C2 and C3 exhibited a better percentage of cell proliferation 
inhibition than that observed in HCT116. In spite of the promising anti-proliferative activity, 
the malignant melanoma cell line seems unaltered regarding an increase of cells with 
nuclear chromatin condensation when exposed to compounds C2 and C3; this may 
suggest that the induction of cell death can occur by a mechanism differing from 
apoptosis, or that the decrease of cell proliferation may be due to an inhibition of 
proliferative pathways. In A375 cells, the anti-proliferative effect of compounds is also 
apparently not influenced by the compound’s ability to damage DNA, since results from 
the comet assay did not indicate feasible DNA damage. Current literature also reports 
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studies with similar compounds, such as the study by Eamvijarn et al. (2013), which 
screened an analogue of chevalone C (C3), sartorypyrone B, obtained from Neosartorya 
tsunodae (KUFC 9213) in A375-C5 melanoma cell line and obtained a half maximal 
growth inhibitory concentration (GI50) of 25 µM (Eamvijarn et al., 2013).  
Compounds C1 and C9 were showed no significant anti-proliferative activity in any of 
the tested cell lines, thus further studies with these compounds were not carried out in our 
study. However, more assays could be done to test their anti-proliferative (or other kind of) 
effects in other cell models before discarding the biomedical potential of the two isolates. 
Buttachon et al. (2012) isolated several identical compounds from a terrestrial strain of 
Neosartorya siamensis (KUFC 6349). Besides other isolated compounds specific to the 
terrestrial strain, compounds C4, C8 and C9 which are common to our marine strain were 
assessed for anti-proliferative activity by Buttachon et al. (2012) in cancer cell lines MCF-7 
(breast adenocarcinoma), A549 (non-small cell lung cancer), SK-MEL-28 (malignant 
melanoma), and U373 and Hs683 (glioblastoma). Results indicated that only compound 
C9 had effect upon a cell line, namely U373, with an IC50 of 90 µM, otherwise, none of the 
remaining compounds exhibited relevant anti-proliferative effects on any of the tested 
lines. In our study, compound C9 did not show any significant activity in liver, skin or colon 
cancer cell lines, thus hinting that compound C9 has a potential activity against a very 
restrictive cell spectrum.  
Like herein, the anti-proliferative effects of compound C3 were also seen by 
Kanokmedhakul et al. (2011), based on the fungus Eurotium chevalieri, from which 
chevalone C (C3) was first isolated, revealing that compound C3 exhibited an IC50 value 
of 8.7 µg/ml in BC1 (breast cancer) cell line. The cited study also described the activity of 
other chevalone derivatives (chevalones A, B and D), where chevalone B was active in 
KB (mouth cancer) and NCI-H187 (small-cell lung cancer) cell lines and chevalone D in 
BC1 cell line, with IC50 values of 2.9, 9.8 and 7.8 µg/ml, respectively (Kanokmedhakul et 
al., 2011). 
Meanwhile, Sodngam et al. (2014) have also described variable cytotoxic activity from 
compounds chevalone C (C3), fiscalin A (C5), epi-fiscalin C (C6) and epi-fiscalin A (C8), 
isolated from wood decomposing fungus Xylaria humosa in NCI-H187 (small cell lung 
cancer), MCF-7 (breast adenocarcinoma) and KB (mouth epidermal carcinoma) cancer 
cell lines (Sodngam et al., 2014). In the study by Sodngam et al. (2014), compound C3 
was active in KB and NCI-H187, with an IC50 of 49.4 and 17.7 µg/ml, respectively. Both 
compounds C6 and C8 were active in MCF-7, with an IC50 of 21 and 24.4 µg/ml, 
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respectively. Compound C5 showed no activity in lung, breast and mouth cancer cell 
lines, whereas our results clearly indicate an effect of this compound in hepatic and colon 
cancer cells. The occurrence of activity in different cancer cell types/lines validates the 
interest and potential of such fungal compounds as prospective chemotherapeutic agents. 
In general, the pyrazinoquinazoline derivatives of the fiscalin family (C5, C6, C7 and 
C8) exhibited a broader anti-proliferative action, having all four compounds acted in at 
least one cell line, and one of the compounds (C6) was effective in all three lines. Overall, 
epi-fiscalin C (C6) was the most effective and promising compound in the inhibition of 
proliferation in all tested cell lines, moreover, this compound held the lowest IC50 values in 
regard to each cell line (from 24 µM to 86 µM). Unfortunately, the stock limitations of 
compound C6 withheld its further testing for the induction of DNA damage and cell death 
herein. When observing results regarding cell death induction, three compounds of the 
fiscalin family induced cell death in two cell lines, HepG2 and HCT116. Overall, the 
pyrazinoquinazoline derivatives (C5, C6, C7 and C8), as well as the quinazoline derivative 
nortryptoquivaline (C2) and the meroterpenoid chevalone C (C3) exhibited promising 
results in terms of anti-proliferative activity and induction of cell death in the cell line 
tested. Since the molecular mechanisms involved remain unknown, further studies are 
worthwhile in the light of our data. 
 
4. Conclusions  
The results obtained with this study demonstrate that the compounds obtained from the 
marine-derived fungus Neosartorya siamensis (KUFA 0017) have significant anticancer 
properties, as evaluated by the means of anti-proliferative activity and cell death induction 
in hepatocellular carcinoma, colon carcinoma and malignant melanoma. Compounds of 
the fiscalin family are of specific interest as they present prominent anticancer bioactivity. 
The present data justify further studies to address the nature of the molecular targets and 
the transduction pathways involved in the bioactive mechanisms of these compounds. 
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4.1. Conclusions and future perspectives 
 
The aim of this study was to assess the in vitro anticancer bioactivity of crude ethyl 
extracts obtained from sponge-derived fungi Aspergillus similanensis KUFA 0013 (E1), 
Neosartorya paulistensis KUFC 7897 (E2), Talaromyces trachsypermus KUFC 0021 (E3) 
and sea fan-derived fungi Neosartorya siamensis KUFA 0017 (E4), as well as of the nine 
compounds – of which eight alkaloids and one terpenoid – isolated from the latter fungus.  
The crude ethyl extracts of marine-derived fungi (E1, E2, E3 and E4) were tested on a 
panel of seven human cancer cell lines, in particular, non-small-cell lung carcinoma 
(A549), hepatocellular carcinoma (HepG2), glioblastoma (U251), breast adenocarcinoma 
(MCF-7), colorectal carcinoma (HT29, HCT116), and malignant melanoma (A375) cells. 
Both extracts Neosartorya paulistensis KUFC 7897 (E2) and Neosartorya siamensis 
KUFA 0017 (E4) presented in vitro anticancer activity by decreasing cell proliferation, in 
most cases exhibiting an inhibition of long-term cell proliferation and induction of cell 
death in melanoma, hepatocellular carcinoma and colon carcinoma.  
In an attempt to identify the compounds responsible for the anticancer effect observed 
in the extract of Neosartorya siamensis KUFA 0017 (E4), nine compounds were isolated, 
namely, 2,4-dihydroxy-3-methylacetophenone (C1), nortryptoquivaline (C2), chevalone C 
(C3), tryptoquivaline H (C4), fiscalin A (C5), epi-fiscalin C (C6), epi-neofiscalin A (C7) and 
epi-fiscalin A (C8), and tryptoquivaline F (C9). Although these compounds are not novel 
and have been isolated from other fungi of terrestrial origin (Buttachon et al., 2012; 
Sodngam, Sawadsitang, Suwannasai, & Mongkolthanaruk, 2014) and assessed for 
anticancer activity in selected cancer cell lines, it is the first time that these compounds 
were screened for anticancer activity in colon, liver and skin cancer cell lines, including 
analysis of cell death induction and assessment of genotoxicity. 
Results demonstrated that the great majority of the compounds, in particular, C2, C3, 
C5, C6, C7 and C8, displayed a significant anti-proliferative activity against the selected 
cell lines, with IC50 values that ranged from 24 to 153 µM, indicating that these 
compounds possess a more enhanced cytotoxic effect in comparison to extract E4. 
Additionally, compounds C2, C5, C7 and C8 were able to induce cell death in 
hepatocellular carcinoma cells, whereas compounds C2, C3 and C5 were able to induce 
cell death in colon carcinoma cell lines. None of these compounds were observed to act 
by the induction of DNA strand breaks and alkali-labile sites. In parallel, none of the 
compounds managed to induce significant cell death in malignant melanoma, in spite of 
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the strong anti-proliferative effect of compounds C2 and C3, observed by the MTT assay. 
The anti-proliferative effect may possibly not be related to DNA damage associated to 
DNA strand breaks, as these were not observed by comet assay. It is thus possible to 
suggest that the anti-proliferative activity of these compounds in A375 cell line is linked to 
inhibition of proliferative pathways and not to a pro-cell death stimulus. The overall results 
obtained screening of anticancer activity of these nine compounds were in accordance to 
those obtained with the extract, thus it is plausible to conclude that these may be some of 
the main compounds acting in the anticancer activity of the extract E4.  
Future perspectives regarding this work should further approach the compounds 
isolated as a result of the in vitro anticancer screening, with particular emphasis on 
reaffirming some of the results obtained with a higher degree of detail, as well as 
pinpointing molecular targets and signal transduction pathways.  
It would be of particular interest to further fundament that the induction of cell death is 
occurring by apoptosis, as well as distinguishing the pathways and gene interactions that 
are occurring, with consequent analysis of DNA fragmentation, mitochondrial membrane 
potential, cytochrome c release, reactive oxygen species (ROS) generation, alongside the 
expression of genes that are highly relevant in apoptosis, such as TP53, Bax and Bcl-2, 
as well as the expression of initiator and effector caspases and proteins involved on DNA 
repair. The analysis of morphological alterations in the cells by electron microscopy may 
also be evaluated. The analysis of whether the extracts and compounds’ anti-proliferative 
activity may be dependent on cell cycle arrest should also be evaluated. In spite of the 
compounds absence of induction of DNA strand breaks and alkali-labile sites, other types 
of DNA damage, such as oxidative and alkylating damage, may be observed in order to 
further conclude about the compound’s overall genotoxicity. 
Considering the results given in Chapter II, that may be considered as very promising, 
there is high relevance in the pursuit of isolating compounds from Neosartorya 
paulistensis KUFC 7897 (E2), with successive screening for anticancer activity and for its 
underlying mechanisms.  
Further studies concerning potential synergistic effects from the combination of isolated 
compounds with commonly used chemotherapeutic drugs seem also relevant to carry out. 
In fact, such approaches have been initiated by our work group, and have so far achieved 
positive and promising results. 
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P1. Cell culture 
 
 
Principle 
The culture of animal cells is based on the maintenance in vitro of disaggregated cells, which may have 
normal (non-neoplastic) or neoplastic origin. Neoplastic cell lines are originally extracted from tumours and 
are then grown in vitro with the addition of appropriate media and other additives to ensure proliferation. The 
control of other conditions, such as temperature, pH, CO2 and O2 tension are essential to maintain durable 
cultures. Cell lines may be maintained for extended passages, provided that they are appropriately sub-
cultured when reaching confluence and that adequate physiological and physiochemical conditions are 
verified at all times. When cell lines are stabilized and growth of successive passages is ensured, cells may 
then be used in the desired experimental assays, this process is initiated by collecting cells and analyzing 
cell density and viability prior to seeding in culture plates (Freshney 2010; Cree 2011). 
References 
Cree, I. A. (2011). Principles of Cancer Cell Culture, Cancer Cell Culture, Vol. 731, pp. 13-26. 
Freshney, R. I. (2010) Subculture and Cell Lines. Culture of Animal Cells: A Manual of Basic Technique and Specialized 
Applications, 6th Edition, John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9780470649367.ch12.
 
  
Materials Assay solutions and reagents 
 
T25 cell culture flasks 
Humidified, controlled temperature/CO2 
incubator 
Laminar flow hood 
Inverted phase contrast microscope 
Neubauer chamber 
 
 
PBS (Phosphate Buffered Saline) buffer 
Cell culture medium (depending on cell line, 
e.g. DMEM, RPMI, MEM, etc.) 
Fetal Bovine Serum (FBS) 
Antibiotics (100 U/ml penicillin and 100 µg/ml 
streptomycin) 
Sodium pyruvate 
Sodium bicarbonate 
HEPES 
0.25% Trypsin/EDTA solution 
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Assay solutions 
Prepare the following assay solutions: 
 
(1) PBS buffer (1X) 
	   Final concentration	   Weight	  
NaCl	   137 mM	   8 g	  
KCl	   2.7 mM	   0.2 g	  
Na2PO4	   10 mM	   1.44 g	  
KH2PO4	   2 mM	   0.24 g	  
 
 
Dissolve the reagents above in 800 ml of ultrapure H2O. Adjust pH to 7.4. Add necessary H2O for a final 
volume of 1 L. Autoclave the solution and store at 4ºC. 
 
(2) Cell culture medium (MEM) 1 2 
	   Final concentration	   Weight / Volume	  
Minimum Essential Medium 
Eagle’s (MEM)	  
9.6 g/L	    4.8 g	  
Sodium bicarbonate	   2.2 g/L 1.1 g 
Sodium pyruvate	   110 mg/L 55 mg 
HEPES	   10 mM 1.192 g 
FBS	   10% 50 ml 
Penicillin / Streptomycin	   1% 5 ml 
Ultrapure H2O	   - 445 ml 
 
Weight the reagents and add into an appropriate glass container. Add ultrapure H2O to a final 
volume of 445 ml and mix until completely dissolved. Inside the laminar flow hood, sterilize the 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 Only applicable for MEM cell culture medium. Each medium has a different final composition. FBS and antibiotics % 
are common for all mediums. 
2 Pre-prepared medium is available from several manufacturers. In this case, only FBS and antibiotics need to be added. 
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solution by filtering using a filter with a 0.2 µM pore. Add the FBS and antibiotics. Store tightly 
sealed at 4ºC. It is recommendable to aliquot the medium into 50 ml tubes in order to preserve the 
stock solution. Be sure to keep one aliquot for each respective cell line. Observe the medium 
periodically in order to avoid contamination. 
 
GENERAL GUIDELINES 
Cell maintenance 3 
 
Starting a new culture 
1. To start a new culture of cells, thaw an aliquot of frozen cells by mixing with appropriate cell 
culture medium. This process must be fast in order to avoid cytoxicity from the DMSO used in 
the freezing medium.  
2. Pipette the cells into a sterile cell culture flask. 
3. Add 4 ml of warm medium into the flask. Gently shake the flask to ensure the cell solution 
covers the entire bottom of the flask. 
4. Incubate at 37ºC and 5% CO2 in a humidified incubator. Cells will have adhered within 24 h.  
5. It is preferable to change the medium the next day in order to remove all traces of DMSO in the 
culture. 
6. The medium must be changed every two days, and cells should be trypsinized at least once a 
week, when reaching confluence. 
 
Changing medium 
1. The medium must be changed every two days. Prior to manipulation, always check the culture 
for confluence and contamination under an inverted microscope. 
2. In a water bath (ensure that the water is not contaminated), pre-heat PBS and appropriate cell 
culture medium to 37ºC. 
3. Remove the medium from the flask; be careful not to scrape the bottom of the flask.  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
3 Cell manipulation must always be done under sterile conditions. Process all steps under a laminar flow hood and use 
aseptic manipulation techniques. 
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4. Wash with 1 ml of PBS, this step may be done twice if desired or if there are plenty of cell 
debris. 
5. Remove the PBS and add 5 ml of cell culture medium. 
6. Incubate at 37ºC and 5% CO2 in a humidified incubator. 
 
Trypsinization (Sub-culturing) 
1. When the cell culture has reached a confluence of about 80 % or more, the cells must be 
trypsinized. 
2. Pre-heat a trypsin solution in a water bath at 37ºC. Both medium and PBS can be left at room 
temperature. 
3. Carefully remove the medium from the flask. Wash twice with 1 ml PBS and remove the PBS. 
4. Add 1 ml of trypsin solution and leave to incubate at 37ºC for 5-7 min. 
5. Observe under a microscope to ensure that cells have detached and are fairly loose from each 
other. 
6. Add 4 ml of medium and resuspend with care. 
7. Remove a given amount of cell solution (depending on the growth speed of the cell line and 
desired confluence date), e.g. sub-cultivation ratio of 1:8 (600 µl into a new flask). 
8. Add medium up to 5 ml. 
9. Incubate at 37ºC and 5% CO2 in a humidified incubator. 
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P2. MTT colorimetric assay 
 
 
Principle 
The MTT colorimetric assay is used to assess cell proliferation and viability. This assay is based 
on the reduction of 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tetrazolium bromide (MTT), a yellow 
water-soluble substrate, into non-soluble purple formazan crystal by the enzymatic activity of the 
cell’s mitochondria (Vega-Avila & Pugsley 2011). Subsequent analysis by reading optical density of 
each sample translates the cellular metabolic activity, which can be used to directly and 
proportionally infer the total number of live cells in a given sample (Van Merloo et al. 2011). The 
data obtained from this assay can be used to perform the calculation of the IC50, which 
corresponds to the concentration of a given compound that decreases the number of viable cells 
by 50% (Dias 2013).  
 
References 
Dias, T. A., Duarte, C. L., Lima, C. F., Proença, M. F., Pereira-Wilson, C. (2013). Superior anticancer activity of 
halogenated chalcones and flavonols over the natural flavonol quercetin. Eur J Med Chem, 65, 500-510 
Van Meerloo, J., Kaspers, G. J., & Cloos, J. (2011). Cell sensitivity assays: the MTT assay. Cancer Cell Culture, pp. 237-
245: Springer. 
Vega-Avila, E., & Pugsley, M. K. (2011). An overview of colorimetric assay methods used to assess survival or 
proliferation of mammalian cells. Paper presented at the Proc West Pharmacol Soc. 
 
  
Materials Assay solutions and reagents 
 
96-multiwell culture plates 
Microplate reader 
 
 
PBS (Phosphate Buffered Saline) buffer 
3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) stock 
solution 
DMSO (dimethyl sulfoxide):ethanol (1:1) 
solution 
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Assay solutions 
Prepare the following assay solutions: 
 
(1) PBS buffer (1X) 
	   Final concentration	   Weight	  
NaCl	   137 mM	   8 g	  
KCl	   2.7 mM	   0.2 g	  
Na2PO4	   10 mM	   1.44 g	  
KH2PO4	   2 mM	   0.24 g	  
 
Dissolve the reagents above in 800 ml of ultrapure H2O. Adjust pH to 7.4. Add necessary H2O for a final 
volume of 1 L. Autoclave the solution and store at 4ºC. 
 
(2) MTT stock solution 4 
	   Final concentration	   Weight	  
3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide 
(MTT)	  
5 mg/ml	   50 mg	  
 
Add 50 mg of MTT and add PBS (1X) to a final volume of 10 ml. Dissolve the solution in an ultrasound bath, 
remember to avoid overheating. Store at -20ºC. 
 
(3) DMSO:ethanol (1:1) 5 
 
Add 250 ml of dimethyl sulfoxide (DMSO) and 250 ml of pure ethanol (100%, v/v). Beware of DMSO toxicity, 
manipulate with care in a fume hood. Store at room temperature and protected from light. 
 
PROTOCOL 
 
Cell preparation 6 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
4 MTT is carcinogenic, handle with care. 
5 DMSO is toxic, beware of any vapours and handle with care. Use rubber or nitrile gloves for extended manipulation. 
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1. In sterile conditions, incubate 100 µl (0.1x106 cells/well) of cell suspension in a 96-multiwell 
culture plate and allow cells to adhere for 24 h in a humidified incubator at 37ºC and 5% CO2. 
2. Treat cells with the desired experimental design. Add 10 µl of MTT solution (0.5 µg/ml) to the 
initial control cells (t = 0). 
3. Incubate in a humidified incubator at 37ºC and 5% CO2 for 2 hours. 
4. Remove the medium of the control cells (t = 0 h) gently, in order to avoid losing the formazan 
crystals. If there are crystals in suspension, the medium must be collected into a tube and 
centrifuged.  
5. Incubate in a humidified incubator at 37ºC and 5% CO2 for the remaining 46 hours (for a 48 h 
assay, depending on cell and treatment type). 
6. Add 10 µl of MTT solution (0.5 µg/ml) to the remaining cells, both final control (t = 48 h) and 
treated cells. 
7. Incubate in a humidified incubator at 37ºC and 5% CO2 for 2 hours. 
8. Remove the medium of all cells, as before (point 2). 
9. Add 150 µl of DMSO:ethanol solvent to dissolve the formazan crystals. 
10. Place the culture plate in a plate shaker and let shake slowly for 10 – 20 min to dissolve the 
crystals. This process must be undergone while protecting the plate from exposure to light.   
11. Once the crystals are completely dissolved, measure the absorbance in a microplate reader at 
570 nm.  
 
Calculations 
The absorbance (A) values obtained for both the initial control (t = 0 h) and final control (t = 48 h) 
allow the calculation of the percentage of cell proliferation, by using the following equation: 
 
Cell proliferation = (A sample - A initial control / A final control - A initial control) 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
6 This protocol must be processed under sterile conditions. 
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P3. Comet assay 
 
 
Principle 
The single cell gel electrophoresis assay, also known as comet assay, is a method developed for 
measuring the level of DNA damage in single cells (Olive & Banáth 2006). When submitted to an 
electric field, loops and fragments of DNA migrate through an agarose gel, subsequently DNA 
migration is directly proportional to DNA damage. The alkaline version (pH > 13) of this assay 
allows the specific detection of alkali-labile sites and DNA strand breaks (Collins 2006). The 
observation of results relies on DNA staining with a fluorochrome such as DAPI and observation 
under a fluorescence microscope. Appropriate software for imaging analysis, such as 
CometScore®, allows the scoring for percentage of DNA damage and the percentage of DNA in the 
comet tail.  
 
References 
 
Collins, A. R. (2004). The comet assay for DNA damage and repair. Mol Biotech, 26(3), 249-261. 
 
Olive, P. L., & Banáth, J. P. (2006). The comet assay: a method to measure DNA damage in individual cells. Nat Prot, 
1(1), 23-29. 
 
  
Materials Assay solutions and reagents 
 
Horizontal electrophoresis tank 
Electric power supply 
Fluorescence microscope 
 
 
PBS (Phosphate Buffered Saline) buffer 
0.25% Trypsin/EDTA solution 
Lysis solution, pH 10 
Electrophoresis Buffer (300 mM NaOH, 1 mM 
Na2EDTA, pH 13) 
1% Normal Melting Point Agarose (w/v) 
0.5% Low Melting Point Agarose (w/v) 
DAPI staining solution (1 µg/ml) 
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Assay solutions 
Prepare the following solutions: 
 
(1) PBS buffer (1X) 
	   Final concentration	   Weight	  
NaCl	   137 mM	   8 g	  
KCl	   2.7 mM	   0.2 g	  
Na2PO4	   10 mM	   1.44 g	  
KH2PO4	   2 mM	   0.24 g	  
 
 
Dissolve the reagents above in 800 ml of ultrapure H2O. Adjust pH to 7.4. Add necessary H2O for a final 
volume of 1 L. Autoclave the solution and store at 4ºC. 
 
(2) Lysis solution, pH 10 
	   Final concentration	   Weight	  
NaCl	   2.5 M	   146.1 g	  
Na2EDTA	   100 mM	   37.22 g	  
Tris Base	   10 mM	   1.211 g	  
NaOH to pH of 10	   	   Approx. 7 g	  
 
 
Add the reagents and ultrapure H2O to a final volume of 990 ml. Store at 4ºC. Prior to use, immediately add 
1% Triton X-100 (v/v). 
 
(3) Electrophoresis Buffer (300 mM NaOH, 1 mM Na2EDTA, pH 13) 
	   Final	  concentration	   Weight	  
NaOH 3 M 120 g 
Add NaOH and distilled water to a final volume of 1 L. Store at room temperature or 4ºC.  
               Na2EDTA 200 mM 3.722 g 
Add Na2EDTA and distilled water to a final volume of 50 ml. Store at room temperature or 4ºC. 
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The electrophoresis buffer must be prepared immediately before use. To prepare 1 L of solution, mix 895 ml 
of distilled water, 5 ml of 200 mM Na2EDTA and 100 ml of 3 M NaOH. Recommended pH is ≥13. It is 
advisable to use this solution only once per set of gels run.  
 
(4) 1% Normal Melting Point Agarose (w/v) 
Dissolve 200 mg of normal melting point (NMP) agarose in 20 ml of distilled water. Heat the solution for 1 – 2 
min in a microwave (full power) until completely dissolved. Store at 4ºC and when required, melt prior to use.  
 
(5) 0.5% Low Melting Point Agarose (w/v) 
Dissolve 100 mg of low melting point (LMP) agarose in 20 ml of PBS. Heat the solution for 1 – 2 min in a 
microwave (full power) until completely dissolved. Aliquot 2 ml of the solution into heat-resistant cryotubes 
and store at 4ºC. Prior to use, melt and maintain at 37ºC in a water bath. 
 
(6)    DAPI staining solution (1 µg/ml) 7 
Prepare a working solution of 1 µg/ml from a stock solution of 100 µg/ml. Dilute in distilled water. Store at -
20ºC, protected from light. 
 
 
PROTOCOL 
 
Slide preparation 
Label conventional microscope slides, preferably in pencil, with the appropriate assay information 
on the glazed area. Melt 1% NMP agarose (w/v) and dip conventional microscope slides in this 
solution. Allow the slides to dry horizontally at room temperature overnight; remember to keep the 
glazed side upwards. Prepared slides may be stored for a few days before use.  
 
Cell preparation 8 
1. In sterile conditions, incubate 1000 µl (0.1x106 cells/well) of cell suspension in a 24-multiwell 
culture plate and allow cells to adhere for 24 h in a humidified incubator at 37ºC and 5% CO2. 
2. Treat cells with the desired experimental design.  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
7 DAPI is carcinogenic, handle with care. 
8 This protocol must be processed under sterile conditions up to step 3. 
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3. Incubate in a humidified incubator at 37ºC and 5% CO2 for 48 hours (depending on your 
experimental design). 
4. Wash cells with warm PBS, remove the PBS and add 150 µl of warm trypsin for 3 –	  5 minutes.  
5. Stop the action of the tryspin by adding 400 µl of culture medium. Resuspend the cells with 
care. Place the plate on ice. 
6. Collect approximately 50.000 cells per well into marked tubes, maintain the tubes on ice. 
 
Comet assay 
7. Centrifuge the cells for 1 min at 5000 rpm. 
8. Remove the supernatant and gently resuspend cells in 100 µl of LMP agarose; the agarose 
must be no warmer than 37ºC, in order to preserve cell integrity. 
9. On the NMP side of a pre-coated and labeled microscope slide, apply a 75 µl drop of the cell 
suspension/LMP agarose mixture.  
10. Immediately cover the drop with a 22 x 22 mm coverslip and place the slides at 4ºC. 
11. Prepare the lysis solution, add Triton X-100. 
12. Remove the coverslips with care and place slides in an adequate slide container. Add the lysis 
solution until the slides are fully immersed.  
13. Incubate at 4ºC for at least 2 h, protected from light. 
14. Prepare the electrophoresis buffer and use it to appropriately fill the horizontal electrophoresis 
tank. Be sure to keep the tank leveled. Maintain the tank at 4ºC. 
15. Remove slides from the lysis solution and carefully rinse the slides in distilled water.  
16. Transfer the slides into the horizontal electrophoresis tank. Set the labeled side towards the 
anode. Proceed with care in order to avoid losing the agarose gel from the slides, as it can 
easily peel off. 
17. To allow the DNA to unwind, incubate the slides in the electrophoresis buffer for 40 min at 4ºC.  
18. Set the power supply to 20 V (1 V/cm) and turn it on. Run the electrophoresis for 20 minutes at 
4ºC. 
19. Remove the slides and immerse in distilled water for 5 minutes, washing twice more for 5 
minutes. 
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20. Dehydrate the slides twice in 100% ethanol for 5 minutes. 
21. Leave the slides to air dry. When ready for analysis, apply 20 µl of working DAPI staining 
solution to each sample and apply a coverslip. From this point on, keep slides away from light. 
22. The samples are now ready to evaluate under a fluorescence microscope. A minimum of 4 
independent experiments is recommended in order to produce feasible results. 
 
Evaluation of DNA damage 
The samples may now be observed under a fluorescence microscope, and resulting images 
analysed by a quantitative method, by the use of appropriate image analysis software (e.g. 
CometScore®), Software analysis expresses results in various forms, namely % of DNA in tail, tail 
length and tail moment. In alternative, the comets may be assessed semiquantitatively by manual 
scoring, refer to Collins et al (1995) for a thorough description. Consider the guidelines below when 
processing your samples. 
 
1. The samples should be analysed by one person only. 
2. Cells should be observed by using a 20x or 40x objective. 
3. It is advisable to score at least 100 cells per sample. 
4. Base your analysis on the scanning of all fields of the sample (see point 5 and 6). Take care 
not to repeat the same areas, to avoid this, analyse your sample from top to bottom.  
5. Be careful not to analyse cells around the edges of the gel, as these may often appear to have 
high levels of damage that do not result from treatment induction.  
6. If the comets seem to have a non-horizontal orientation, there has probably been a problem 
during the electrophoresis. Keep the tank leveled and the slides as horizontal as possible while 
running the gel. Be sure to repeat the procedure for these samples. 
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P4. Nuclear condensation assay 
 
 
Principle 
Cell death by apoptosis is characterized by a series of morphological features such as cell 
shrinkage, membrane blebbing, chromatin condensation and nuclear fragmentation (Kroemer et al. 
2009). In normal conditions, chromatin is loosely packaged in the nucleus. In the event of mitosis, 
chromatin is condensed and organized into chromosomes. However, during the induction of 
apoptosis, chromatin is heavily condensed alongside nuclear proteins and forms the hallmark 
apoptotic bodies. This assay comprises the staining of cell nuclei with DAPI (4’,6-diamidino-2-
phenylindole), a fluorochrome which binds to the A-T regions of the DNA, and allows the 
observation of nuclear chromatin condensation (Toné et al. 2007).  
 
References 
Kroemer, G., Galluzzi, L., Vandenabeele, P., Abrams, J., Alnemri, E. S., Baehrecke, E. H., . . . Melino, G. (2009). 
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death 
Differ, 16(1), 3-11. doi: Doi 10.1038/Cdd.2008.150 
Toné, S., Sugimoto, K., Tanda, K., Suda, T., Uehira, K., Kanouchi, H., et al. (2007). Three distinct stages of apoptotic 
nuclear condensation revealed by time-lapse imaging, biochemical and electron microscopy analysis of cell-free 
apoptosis. Exp Cell Res, 313(16), 3635-3644. 
 
  
Materials Assay solutions and reagents 
 
24-multiwell culture plates 
Poly-L-Lysine microscope slides 
Hydrophobic barrier pen 
Centrifuge 
Cytocentrifuge filters 
Cytocentrifuge 
Fluorescence microscope  
 
PBS (Phosphate Buffered Saline) buffer 
0.25% Trypsin/EDTA solution 
4% Paraformaldehyde (PFA) (w/v) 
DAPI staining solution (1 µg/ml) 
50% Glycerol solution 
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Assay solutions 
Prepare the following solutions: 
 
(1) PBS buffer (1X) 
	   Final concentration	   Weight	  
NaCl	   137 mM	   8 g	  
KCl	   2.7 mM	   0.2 g	  
Na2PO4	   10 mM	   1.44 g	  
KH2PO4	   2 mM	   0.24 g	  
 
Dissolve the reagents above in 800 ml of ultrapure H2O. Adjust pH to 7.4. Add necessary H2O for a final 
volume of 1 L. Autoclave the solution and store at 4ºC. 
 
(2) 4% Paraformaldehyde (w/v) 9 
	   Final concentration	   Weight	  
Paraformaldehyde (PFA)	   4%	   4 g	  
 
Add 4 g of PFA and PBS up to a final volume of 100 ml. Place the solution in a 60ºC water bath. Beware of 
any vapours, keep the lid tightly closed. Stir the solution periodically. When completely dissolved, let the 
solution cool down and adjust the pH to 7.4. Aliquot as desired and store at -20ºC. 
 
(3) DAPI staining solution (1 µg/ml) 10 
Prepare a working solution of 1 µg/ml from a stock solution of 100 µg/ml. Dilute in distilled water. Store at -
20ºC, protected from light. 
 
(4) 50 % Glycerol solution 
Add 5 ml of pure glycerol and 5 ml of PBS (1X). The solution must be vortexed thoroughly, as it is difficult to 
dissolve glycerol. Store at 4ºC. 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
9 PFA solution is toxic, beware of vapours and handle with care. 
10 DAPI is carcinogenic, handle with care. 
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PROTOCOL 
 
Cell preparation 11 
1. In sterile conditions, incubate 1000 µl (0.1x106 cells/well) of cell suspension in a 24-multiwell 
culture plate and allow cells to adhere for 24 h in a humidified incubator at 37ºC and 5% CO2. 
2. Treat cells with the desired experimental design.  
3. Incubate in a humidified incubator at 37ºC and 5% CO2 for 48 hours (depending on your 
experimental design). 
4. Collect the medium into a centrifuge tube labeled with the sample number. Wash cells with 1 
ml warm PBS; recover the PBS into the respective tube. Add 150 µl of warm trypsin to the 
cells for 3 –	  5 minutes.  
5. Stop the action of the tryspin by adding 400 µl of culture medium. Resuspend the cells with 
care.  
6. Recover the medium and cells into the tube. Wash the wells with 1 ml PBS and recover into 
the respective tube.  
7. Centrifuge the samples at 2000 rpm for 10 min.  
8. Discard all the supernatant until 500 µl and resuspend the pellet with 3 ml of PBS. 
9. Centrifuge the samples once more at 2000 rpm for 10 min.  
10. Discard all the supernatant until 500 µl and resuspend the pellet with 2 ml of PFA. 
11. Incubate at 37ºC for 15 –	  20 min. 
12. Discard all the supernatant until 500 µl and resuspend the pellet with 4 ml of PBS. 
13. Centrifuge the samples at 2000 rpm for 10 min.  
14. Discard all the supernatant until 500 µl, collect this supernatant into labeled tubes and store at 
4ºC. The samples can be stored at 4ºC for a few months. 
15. Label poly-L-Lysine microscope slides accordingly. Prepare filters and mount the slides onto 
the cytocentrifuge frames. Pipette 80 µl (depending on cell density) of cell sample into the 
respective cytocentrifuge tube. Each slide can fit two samples, one on each side. Run the 
cytocentrifuge at 500 rpm for 5 min. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
11 This protocol must be processed under sterile conditions up to step 3. 
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16. Unmount the frames and leave the slides to air dry. 
17. Circle the samples with a hydrophobic barrier pen. 
18. Wash the slides three times with PBS, for 5 min each turn. 
19. Incubate each sample with 20 µl of DAPI staining working solution for 10 min in the dark.  
20. Add a 6 µl drop of 50 % glycerol solution to each sample and cover with a 22 x 22 mm 
coverslip. Store the samples at -20ºC, protected from light. 
 
Analysis of nuclear condensation 
Observe the samples under a fluorescence microscope. Observe at least 300 cells per sample, in 
at least 3 different areas. Count both the total number of cells and the number of cells presenting 
condensed nuclei. The percentage of cells with condensed nuclei is determined according to the 
ratio between total number of cells presenting condensed nuclei and the total number of cells.  
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P5. Clonogenic assay 
 
 
Principle 
The clonogenic assay is a simple and effective cell survival assay by which it is possible to 
determine the long-term ability of a single cell to form a colony (Munshi et al. 2005). This assay is 
mainly used to assess the whether a chemical agent presents cytostatic activity, thus definitively 
arresting indefinite proliferation of cells by reducing reproductive viability (ability of a single cell to 
form a colony of 50 or more cells) in treated cells in relation to untreated cells (control) (Franken et 
al. 2006). 
 
References 
Franken, N. A., Rodermond, H. M., Stap, J., Haveman, J., & Van Bree, C. (2006). Clonogenic assay of cells in vitro. Nat 
Prot, 1(5), 2315-2319. 
Haloom, R., Christian, O., George T, G., Katherine, V., Assam, E-O., & Tom C, K. (2011). Clonogenic Assay: Adherent 
Cells. J Vis Exp (49).  
Munshi, A., Hobbs, M., & Meyn, R. E. (2005). Clonogenic cell survival assay. Chemosensitivity (pp. 21-28): Springer. 
 
 
 
  
Materials Assay solutions and reagents 
 
12 and 24-multiwell culture plates 
Stereomicroscope 
Laminar flow hood 
 
 
PBS (Phosphate Buffered Saline) buffer 
0.25% Trypsin/EDTA solution 
4% Paraformaldehyde (PFA) (w/v) 
0.05% Crystal violet (w/v) 
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Assay solutions 
Prepare the following solutions: 
 
(1) PBS buffer (1X) 
	   Final concentration	   Weight	  
	   	   	  
NaCl	   137 mM	   8 g	  
KCl	   2.7 mM	   0.2 g	  
Na2PO4	   10 mM	   1.44 g	  
KH2PO4	   2 mM	   0.24 g	  
 
 
Dissolve the reagents above in 800 ml of ultrapure H2O. Adjust pH to 7.4. Add necessary H2O for a 
final volume of 1 L. Autoclave the solution and store at 4ºC. 
 
 
 
(2) 4% Paraformaldehyde (w/v) 12  
	   Final concentration	   Weight	  
Paraformaldehyde (PFA)	   4%	   4 g	  
 
 
Add 4 g of PFA and add PBS up to a final volume of 100 ml. Place the solution in a 60ºC water 
bath. Beware of any vapours, keep the lid tightly closed. Stir the solution periodically. When 
completely dissolved, let the solution cool down and adjust the pH to 7.4. Aliquot as desired and 
store at -20ºC. 
 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
12 PFA solution is toxic, beware of vapours and handle with care. 
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(3)  0.05% Crystal violet (w/v) 
	   Final concentration	   Weight	  
Crystal violet	   0.05%	   5 mg	  
	   	   	  
Add 5 mg of crystal violet and PBS up to a final volume of 100 ml. Mix thoroughly until completely 
dissolved. Store at room temperature, protected from light. 
 
 
 
 
PROTOCOL 
 
Cell preparation 13 
1. In sterile conditions, incubate 1000 µl (0.1x106 cells/well) of cell suspension in a 24-
multiwell culture plate and allow cells to adhere for 24 h in a humidified incubator at 
37ºC and 5% CO2. 
2. Treat cells with the desired experimental design.  
3. Incubate in a humidified incubator at 37ºC and 5% CO2 for 48 hours (depending on 
your experimental design). 
4. Wash cells with warm PBS. Add 150 µl of warm trypsin to the cells for 3 –	  5 minutes.  
5. Stop the action of the tryspin by adding 400 µl of culture medium. Resuspend the 
cells with care. 
6. Prepare serial dilutions for a final dilution of 200 cells in 1 ml of culture medium. Be 
sure to resuspend thoroughly. 
7. Plate 1 ml with 200 cells per well in 12-multiwell culture plates.  
8. Incubate in a humidified incubator at 37ºC and 5% CO2 for 10 days. 
9. After 10 days of culture, remove the medium and wash with 2 ml of warm PBS. 
10. Fix the cells in situ with 2 ml of 4% PFA. Incubate for 15 min at 37ºC. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
13 This protocol must be processed under sterile conditions up to step 9. 
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11. Remove the PFA and wash with 2 ml of warm PBS. Remove the PBS. 
12. Incubate with 2 ml 0.05% crystal violet for 30 min at room temperature. 
13. Wash with distilled water, remove the water and leave to air dry. 
14. Count colonies with more than 50 individual cells using a stereomicroscope. 
 
Calculations 
The plating efficiency (PE) is calculated from the ratio between the number of colonies (> 
50 cells) counted and the number of cells plated. Subsequently, the surviving fraction 
(relative to control) is calculated by using the following equation:  
 
% Surviving fraction (SF) = (PE treated cells / PE control) x 100 
 
 
 
